CURRICULUM VITAE LEONIDPORETSKY,M.D.

11/13/2019 ADDRESS: Home: 1025FifthAvenue,#8ES NewYork,N.Y.10028

Business:NorthwellHealth–LenoxHillHospital100East77thStreetNewYork,N.Y.10075

TELEPHONE: (212)434-4972(office)DATEOFBIRTH: August7,1954PLACEOFBIRTH: Leningrad,Russia(USSR)CITIZENSHIP: UnitedStates,1985

ImmigratedtoU.S.A.in1979MEDICALSCHOOL:1971-1977 M.D.,CumLaude

FirstMedicalInstituteLeningrad,Russia(USSR)

CURRENTPOSITIONS: 2014–Present Chief,DivisionofEndocrinology AssociateChairman,DepartmentofMedicine NorthwellHealth–LenoxHillHospital NewYork,NewYork10075

ProfessorofMedicine DonaldandBarbaraZuckerSchoolofMedicineatHofstraNorthwell

PREVIOUSHOSPITALAPPOINTMENTS:2000–2014 InterimChairman,DepartmentofMedicine(2014) Chief,DivisionofEndocrinology&Metabolism(2000)

GeraldJ.FriedmanChairinEndocrinology(2004) ProgramDirector,FellowshipinEndocrinologyandMetabolism(2000) Director,GeraldJ.FriedmanDiabetesInstitute(2007) ResearchIntegrityOfficer(2012) MountSinaiBethIsrael NewYork,NewYork

2012–2014 Vice-ChairmanforResearch,DepartmentofMedicine MountSinaiBethIsrael NewYork,NewYork

LEONIDPORETSKY,M.D.

2

1995-2000 Director,DiabetesCenterAssociateDirector,GeneralClinicalResearchCenterProfessorofMedicineandGynecology(1999)NewYorkHospital/CornellMedicalCenterNewYork,NewYork

1989-1995 Chief,DivisionofEndocrinologyandMetabolism,

CabriniMedicalCenterNewYork,NewYork

1985-1989 Head,DiabetesSection

DivisionofEndocrinologyandMetabolismDepartmentofMedicineBethIsraelMedicalCenterNewYork,NewYork

1983-1985 FellowinEndocrinology,

BethIsraelHospitalBoston,Massachusetts

1983-1985 Physician(part-time),JoslinDiabetesCenter,Boston,Massachusetts

1982–1983 ChiefResidentinMedicine, ConeyIslandHospital, Brooklyn,NewYork1980–1982 ResidentinMedicine, ConeyIslandHospital, Brooklyn,NewYork1978-1979 Physician,MedicalEmergencyStation

Leningrad,Russia(USSR)1977-1978 Physician,

DepartmentofInternalMedicineStateHospitalNumber21Leningrad,Russia(USSR)

PREVIOUSMEDICALSCHOOLAPPOINTMENTS:2000-2014 ProfessorofMedicine,AlbertEinsteinCollegeofMedicine(2000)

ProfessorofMedicine,IcahnSchoolofMedicineatMountSinai(2014)1999-2000 ProfessorofMedicineandGynecology WeillMedicalCollegeofCornellUniversity NewYork,NewYork

LEONIDPORETSKY,M.D.

3

1995-1999 AssociateProfessorofMedicineandGynecologyCornellUniversityMedicalCollegeNewYork,NewYork

1990-1995 AssociateProfessorofMedicine

NewYorkMedicalCollegeValhalla,NewYork

1989-1990 AssociateProfessorofMedicine

Mt.SinaiSchoolofMedicineCityUniversityofNewYorkNewYork,NewYork

1985-1989 AssistantProfessorofMedicine

Mt.SinaiSchoolofMedicineCityUniversityofNewYorkNewYork,NewYork

POSTDOCTORALTRAINING:2003 MedicalInformaticsMBL/NLMCourseFellow

MarineBiologicalLaboratorySponsoredbytheNationalLibraryofMedicineWoodsHole,Massachusetts

1983-1985 ResearchFellowinMedicine,

HarvardMedicalSchool,CharlesA.DanaResearchInstituteandTheHarvard-ThorndikeLaboratory.FellowinEndocrinologyandDiabetes,Boston’sBeth IsraelHospital,with clinical duties atBrighamMedicalGroupandHarvardCommunityHealthPlan,Boston,Massachusetts

1982-1983 ChiefResident,

DepartmentofMedicine,ConeyIslandHospital,Brooklyn,NewYork

1980-1982 ResidentinMedicine,

ConeyIslandHospital,Brooklyn,NewYork

LICENSUREANDCERTIFICATION:1985 Diplomate

AmericanBoardofEndocrinologyandMetabolismCert.#90042

LEONIDPORETSKY,M.D.

4

1983 Diplomate,AmericanBoardofInternalMedicineCert.#900421996 PennsylvaniaStateLicenseRegistration#MD-057239-L1983 NewYorkStateLicenseRegistration#155121-11983 MassachusettsLicenseRegistration#510421982 CaliforniaLicenseRegistration#A392571981 MarylandLicenseRegistration#D269361981 FLEXExaminationpassedJune,19811980 ECFMGCertificate#314376-6TEACHINGEXPERIENCE:2014-Present Chief,DivisionofEndocrinology,DiabetesandMetabolism AssociateChairmanforResearch,DepartmentofMedicine

LenoxHillHospital Professor of Medicine, Donald and Barbara Zucker School of Medicine at HofstraNorthwellandFeinsteinInstituteforMedicalResearchTeaching rotatinghighschool, collegeandmedical students;mentoring residents inmedicine and fellows in endocrinology. Co-Director,weekly divisional conferencesand annual Feinstein Institute research symposia “Diabetes, endocrinology andmetabolicdisorders.”

2000-2014 Chief,DivisionofEndocrinologyandMetabolism,

BethIsraelMedicalCenter.Teachingmedicalstudents,residentsandfellows.

ProgramDirectorforthefellowshiptrainingprogram. 1995-2000 Director,DiabetesCenter,NewYorkHospital-

CornellMedicalCenter,NewYork,NYFacultyMember for the following problem based learning (PBL) courses: “HumanStructureandFunction”and“FromMoleculestoCells”.Preceptorforthetriplejumpexamination(2ndyearmedicalstudents).Writingquestionsforthepathophysiologyexamination (2nd year medical students). Lectures for medical students: “Type 1diabetes mellitus” and “Insulin and glucagon.” Endocrine grand rounds: “Role ofinsulin and insulin-like growth factors in ovarian function” and “Polycystic ovarysyndrome.” Medical grand rounds: “Syndromes of insulin resistance.” Teachingresidents and fellows in clinical setting (attending ward physician in internalmedicineandendocrinology;attendingphysicianintheendocrineclinicandhigh-riskpregnancy clinic). Member, Cornell University Medical College Department ofMedicine Postgraduate Education Advisory Committee and Update in MedicineCommittee.LecturesthroughoutNewYorkMetropolitanareaonthetopicofinsulin

LEONIDPORETSKY,M.D.

5

resistance (Columbia University, New York University School of Medicine, MountSinaiSchoolofMedicine,AlbertEinsteinCollegeofMedicine).

1989-1995 Chief,DivisionofEndocrinologyandMetabolism

CabriniMedicalCenter,NewYork,NYRoundswithhousestaffandmedicalstudents inendocrinology& internalmedicine.Organizing endocrine conferences and board review courses for residents.Organizing inter-institutional endocrine grand rounds, (Cabrini Medical Center, St.VincentMedical Center,Rogosin Institute). Lecturingon insulin receptordisordersandendocrinologicalaspectsofAIDS.

1985-1989 Head,DiabetesSectionBethIsraelMedicalCenter,NewYork,NY

Conducting rounds with housestaff and medical students; responsible for weeklyendocrine grand rounds and monthly research conferences. Lecturing on insulinreceptordisorders.

1983-1985 FellowinEndocrinologyandMetabolism,Boston’sBethIsraelHospitalandHarvard

MedicalSchoolWhile on clinical service, supervised students and residents rotating through theservice; presented endocrine grand rounds on the following subjects: Lipoatrophicdiabetes;Insulinreceptorsinhealthanddisease;andInsulineffectsintheovary.

1982-1983 ChiefResident,DepartmentofMedicine,Coney IslandHospital,Brooklyn,NewYork

Teaching residents in a clinical setting; conducting daily MICU rounds and weeklyclinicalconferences.

1982-1983 Preceptor for Physical Diagnosis Course, Sophie Davis School of Biomedical

Education,CityUniversityofNewYork.1971-1977 Teachingbiologycourseforpremedicalstudents,

FirstMedicalInstitute,Leningrad,Russia(USSR).COMMITTEEMEMBERSHIPS:CommitteeonScholarlyActivities,MountSinaiBethIsrael,NewYork,NewYorkDepartmentofMedicineDivisionChiefs,MountSinaiBethIsrael,NewYork,NewYorkDiabetesCareEnhancementInitiativeCommittee,BethIsraelMedicalCenter,NewYork,NewYorkMAJORRESEARCHINTERESTS:Mechanismsof insulinandinsulin-likegrowthfactoractionintheovary;endocrinologicalaspectsofAIDS;clinicaloutcomesindiabetes.GrantSupport:2019-Ongoing Mentor(LenoxHillHospital)–“TransgenderHealthAgingStudyandRegistry”–NY

StateDepartmentofHealth,EmpireClinicalResearchProgram(ECRIP).Directcosts$574,166.00.

LEONIDPORETSKY,M.D.

6

2017-Ongoing ProjectDirector(LenoxHillHospital)–“Obesityasamultifactorialdisease:Energy metabolism,insulinresistance, microbiomeandendoscopicbariatricintervention in human obesity” – NY State Department of Health, Empire Clinical Research

Program(ECRIP).Directcosts$698,8882017-Ongoing Site Principal Investigator – Role of CAP1 in mediating resistin action in obesity-

inducedinsulinresistance.GeraldJ.andDorothyR.FriedmanNewYorkFoundationforMedicalResearch

2017–Ongoing SiteCo-Investigator–Novartis (Site-Principal Investigator–Dr. JohnBoockvar): A

Phase III,multi-center, randomized, double blind, 48week studywith an initial 12weekplacebo-controlledperiodtoevaluatethesafetyandefficacyofosilodrostat inpatientswithCushing’sdisease.

2015–Ongoing SitePrincipalInvestigator–“Theeffectofstructuredoutpatientdiabetesprogramonhospitalreadmissionratesinpatientswithdiabetes”-NYStateDepartmentofHealth,EmpireClinicalResearchInvestigationProgram(ECRIP).Initiallyfunded2015-2017,directcosts$150,000.00

2017-2019 Site Principal Investigator – Sanofi: Sotagliflozin compared to empagliflozin and

placebo in patientswith type 2 diabeteswho have inadequate glycemic control onDipeptidyl Peptidase 4 Inhibitor (DPP4I)with orwithoutmetformin -amulticenterclinicaltrial.

2017-2019 SitePrincipal Investigator–Sanofi: TheSCOREDTrial, a randomized,doubleblind,

placebo-controlled, parallel-group, multicenter study to demonstrate the effects ofsotagliflozin on cardiovascular and renal events in patients with type 2 diabetes,cardiovascular risk factors and moderately impaired renal function, a multi-centerclinicaltrial.

2016–2019 SiteCo-Investigator(LenoxHillHospital);NIDDKGrantNumberUO1DK098245-03.

VitaminD and type 2 diabetes (D2d study). Principal Investigator: Anastassios G.Pittas,MD,TuftsUniversity.IRBNo.HS16-0144.

2016–2017 SitePrincipalInvestigator-Sanofi:APhaseIVrandomized,open-label,parallelgroup

realworldpragmatictrialtoassesstheclinicalandhealthoutcomesofToujeocomparedtocommerciallyavailablebasalinsulinsforinitiationoftherapyininsulinnaïvepatientswithuncontrolledtype2diabetesmellitus.

2016–2017 SitePrincipalInvestigator-Novartis:Amulti-center,randomized,open-label,Phase

IVstudytoinvestigatethemanagementofpasireotide-inducedhyperglycemiawithincretinbasedtherapyorinsulininadultpatientswithCushing’sdiseaseoracromegaly.

2014 Satellite Principal Investigator (Beth Israel); NIDDK Grant Number NCT02017171.Preventing Early Renal Loss in Diabetes (PERL): A multicenter clinical trial ofallopurinoltopreventGFRlossintype1diabetes.PrincipalInvestigator:AlessandroDoria,MDPhDMPH,JoslinDiabetesCenter.DirectCost:$315,850.00.

LEONIDPORETSKY,M.D.

7

2013–2014 Site Principal Investigator (Beth Israel); NIDDK Grant Number U01DK098245(implementation phase). Vitamin D and type 2 diabetes (D2d study). PrincipalInvestigator:AnastassiosG.Pittas,MD,TuftsUniversity.DirectCost:$153,583.00.

2012–2013 SitePrincipal Investigator (Beth Israel); Genzyme Inc.,MountSinaiMedicalCenter.

Multi-center study of the effect of Sevelamer carbonate onmetabolic/inflammatory/reactive oxygen speciesmarkers in diabetes patientswithnephropathy. Principal Investigator: GaryStriker,MD,MountSinaiMedicalCenter.DirectCost:$119,844.00.

2011–2013 Co-Investigator, NIH National Center for Minority Health and Health Disparities,

Bronx Center to Reduce and Eliminate Ethnic and Racial Health Disparities, AlbertEinsteinCollegeofMedicine. Activatingpeople fordiseaseprevention and lifestylechangethroughempowerment(APPLE).PrincipalInvestigator:AlisonKarasz,Ph.D.,AlbertEinsteinCollegeofMedicine.

2011-2012 Co-investigator;NIDDKGrantNumberU34DK091958(planningphase).VitaminDfor

preventionoftype2Diabetes(D2Dstudy).PrincipalInvestigator:AnastassiosPittas,MD,TuftsUniversity.DirectCost:$161,463.00.

2009–2014 Advisor; NIH #K07AT004570-01A2. Academic career development award in

Complementary and Alternative Medicine Research and Education. PrincipalInvestigator:BenjaminKligler,MD,MPH,BethIsraelMedicalCenter.

2009–2011 Co-investigator; Chinese American Medical Society and Chinese American

IndependentPracticeAssociationResearchFund.Geneticmarkersforincreasedriskof gestational diabetes in Chinese-Americans. Principal Investigator: Donna Seto-Young,Ph.D,BethIsraelMedicalCenter.

2011–2012 Site Principal Investigator; United Hospital Fund. Health coaches—assist patients

with diabetes in managing their illness and help them navigate the health caresystem.DirectCost:$37,830.00.

2009–2011 Sponsor/Mentor;EmpireClinicalResearchInvestigatorProgram,NewYork

StateDepartmentofHealth.TheRoleofThiazolidinedionesinBoneMetabolism2008-2010 SitePrincipalInvestigator;Queens/SouthAsianActionforDiabetes

EducationProgramandTreatment(ADEPT),NewYorkStateHealthFoundation.DirectCost:$269,803.

2008–2010 Sponsor/Mentor;EmpireClinicalResearchInvestigatorProgram,NewYorkState

DepartmentofHealth.Effectsofexenatideinoverweightpatientswithpolycysticovarysyndrome(PCOS)androleofexenatideinhumanovarianregulation.

2008–2014 SitePrincipalInvestigator;Apilotrandomizedcontrolledtrialtoevaluatetheeffects

of education programs, including an interactive web site, on clinical outcomes inpatientswithdiabetes.GeraldJ.FriedmanDiabetesInstitute

2002–2014 SitePrincipal Investigator;GeraldJ.FriedmanFoundation. Receptormechanismsof

insulinandinsulin-likegrowthfactorsinovarianfunction.

LEONIDPORETSKY,M.D.

8

2004-2008 SitePrincipalInvestigator;Glaxo-SmithKline, Inc.Theeffectofthiazolidinedionesoninflammatorymarkersandoutcomesinpatientsundergoingcoronaryarterybypassgraftsurgery.

2006–2008 Sponsor/Mentor; Empire Clinical Research Investigator Program, New York State

Department of Health. Administration of Vitamin D analog to new onset type 1diabetesmellituspatientstorestorepancreaticcellfunction

2005–2007 Investigator/Mentor;EmpireClinicalResearchInvestigatorProgram,NewYorkState.

Comparisonoftheeffectoforalcontraceptiveagents,spironolactone,metforminandrosiglitazone on plasma androgen levels and clinical manifestations ofhyperandrogenesiminwomenwithpolycysticovarysyndrome.

2004–2006 Sponsor/Mentor; Empire Clinical Research Investigator Program, New York State.

VitaminDdeficiencyandinsulinresistance.2003–2005 Sponsor/Mentor; Empire Clinical Research Investigator Program, New York State.

The use of intensive insulin therapy in diabetic and non-diabetic individualsundergoingcoronaryarterybypassgraftsurgery.

2002–2004 Site Principal Investigator; Pharmacia, Inc. Role of thiazolidinediones in the human

ovary.2000–2006 Site Principal Investigator (Beth Israel Medical Center); ADOPT trial; Glaxo-Smith-

Kline,Inc.2000–2005 Co-investigator;NIHR01-MH60563.DHEAeffectsonmoodinHIVpositivepatients.

PrincipalInvestigator:JudyRabkin,Ph.D.,ColumbiaUniversity.2000–2002 Site Principal Investigator; Singer/Hellman Award. Receptormechanisms of insulin

actioninthehumanovary.1998–2000 SitePrincipalInvestigator;NICHDR035618-01A1:Receptormechanismsof insulin-

likegrowthfactorIIactionintheovary.1999–2000 Co-Investigator;N01-HC-95184(NHLBI-NIDDK)PreventionofCardiovascularDisease

inDiabetesMellitus.PrincipalInvestigator:J.ThomasBigger,M.D.,ColumbiaUniversity.1995–2000 Cornell University Medical College General Clinical Research Center, Associate Program

Director;NIHGrant#M01RR00047-35.1996–2000 Clinicaltrialofpioglitazoneindiabetes,Takeda,Inc.1997–2000 Combinationtrialofmetforminandsulfonureaindiabetes,Bristol-Myers,Inc.1987–1992 SitePrincipalInvestigator,

NIH–Grant#R29-HD22738,RoleofInsulinandInsulin-likeGrowthFactorsinOvarianFunction.

1986–1988 SitePrincipalInvestigator,

UnitedParcelServiceResearchinMedicineAward;RoleofInsulininOvarianFunction.

LEONIDPORETSKY,M.D.

9

1989–1990 SitePrincipalInvestigator,HerbertSingerCollaborativeResearchAwardatBethIsraelMedicalCenter: AnimalModelofPolycysticOvarySyndrome.

1989–1990 Co-PrincipalInvestigator,

Insulin Receptor Abnormalities in Polycystic Ovary Syndrome NIH-Grant#R01DK40605.

1989–1995 SitePrincipalInvestigator

RobertoPopeEndocrinologyResearchFundatCabriniMedicalCenter:Roleofinsulinandinsulin-likegrowthfactorsinovarianfunctions

1992–1994 SitePrincipalInvestigator,

DiabetesLengthofStayReductionProject,UnitedHospitalFundofNewYork

1992–1994 SitePrincipalInvestigator, DiabetesandMetabolismUnitProject,

FanFoxLeslieR.SamuelsFoundationRESEARCH-RELATEDACTIVITIES:1987 Member, Special Review Committee Reproductive Disorders of Women National

InstituteofChildHealthandHumanDevelopment(NICHD)1991 Member,CooperativeSpecializedInfertilityCenterProgramPanel,NICHD,NIH1992 Member, Specialized Population Research Center site visit team, University of

California,SanDiego,NICHD,NIH1992 Reviewerofgrants,MedicalResearchCouncil,UnitedKingdom1994 ReviewerofGrants,InternationalScienceFoundation1987–present Reviewerofmanuscriptsforthefollowingjournals:

JournalofClinicalEndocrinologyandMetabolism MetabolismTransplantationObesityResearchFertility&Sterility

1996–present BoardofDirectors MetropolitanDiabetesSociety NewYork,NewYork1997–present ReviewerofGrants,EndocrineFellows’Foundation1997–2008 AdvisoryBoards:

NationalDiabetesEducationInitiative(Parke-Davis)NationalEndocrinologyConsultantsInitiative(Bayer)Women’sHealthInitiative(Parke-Davis)

LEONIDPORETSKY,M.D.

10

RosiglitazoneAdvisoryBoard(Smith-Kline/Beecham)BasalInsulinAdvisoryBoard(Hoechst-Marion-Roussel)NationalACTOSAdvisoryBoard(Lilly/Takeda)DiabetesConsultantPanelMember(Aventis)

2008–2012 EditorialBoard,JournalofClinicalEndocrinologyandMetabolism2008-2018 EditorialBoard,JournalofDiabetes2010–2014 EditorialBoard,InternationalScholarlyResearchNetworkEndocrinology EditorialBoard,WorldJournalofDiabetes2014 GuestEditor,EndocrineClinicsofNorthAmerica,specialissues, “Complicationsofdiabetes”and“Diabetesanditsassociatedconditions”.2015-present SeriesEditor,“Contemporaryendocrinology”,Springer,Inc.

KöhlerTSandMcVaryKT,Editors,“Contemporarytreatmentoferectiledysfunction:Aclinicalguide”,2nded,2016,Springer,Inc.ISBN-10:3319315854.

PacakKandTaïebD,Editors,“Diagnosticandtherapeuticnuclearmedicinefor neuroendocrinetumors”,2017,Springer,Inc.DOI10.1007/978-3-319-46038-3. WintersSJandHuhtaniemiIT,Editors,“Malehypogonadism:Basic,clinicaland therapeuticprinciples”,2nded,2017,Springer,Inc.DOI10.1007/978-3-319-53298-1. LiaoEP,Editor,“ExtraskeletaleffectsofvitaminD,”2018,Springer,Inc. DOI10.1007/978-3-319-73742-3. LevineAC,Editor,“Adrenaldisorders:Physiology,pathophysiologyandtreatment,” 2018,Springer,Inc.DOI10.1007/978-3-319-62470-9. GharibH,Editor,“Thyroidnodules:Diagnosisandmanagement,”2018,Springer,Inc., DOI10.1007/978-3-319-59474-3. FreemarkMS,Editor,“PediatricObesity:Etiology,pathogenesisandtreatment,” 2018,Springer,Inc.,DOI10.1007/978-3-319-68192-4. LansbergL,Editor,“Pheochromocytomas,paragangliomasanddisordersofthe sympathoadrenalsystem,”2018,Springer,Inc.,DOI10.1007/978-3-319-77048-2. DeLeon-CrutchlowDDandStanleyCA,Editors,“Congenitalhyperinsulinism: Apracticalguidetodiagnosisandmanagement,”2019,Springer,Inc., DOI10.1007/978-3-030-02961-6. KohnB,Editor,“Pituitarydisordersofchildhood:DiagnosisandClinical Management,”2019,Springer,Inc.,DOI10.1007/978-3-030-11339-1. PoretskyLandHembreeWC,Editors,“Transgendermedicine:Amultidisciplinary approach,”2019,Springer,Inc.,DOI10.1007/978-3-030-05683-4.

LEONIDPORETSKY,M.D.

11

SELECTEDINVITEDLECTURESANDPANELS:

11th International Symposium on Immunology of Reproduction of the International CoordinationCommitteeforImmunologyofReproduction.Topic:Insulinandperoxisomeproliferators-activatedreceptor-γsignalinginthehumanovary:Basicmechanismandclinicalimplications.Varna,Bulgaria,June2-4,2006.PresentedbyDonnaSeto-Young,Ph.D.International SymposiumonPCOS inHarbinChina,August, 2006. Topic: Insulin andperoxisomeproliferators-activated receptor-γ signaling in the human ovary: Basic mechanism and clinicalimplications.PresentedbyDonnaSeto-Young,Ph.D.

GlobalHealthCareConference.Topic:Diabetes.NewYork,May22-24,2007.

SessionChair, “Androgenicdisorders inwomen,” the89thAnnualMeetingof theEndocrineSociety,Toronto,Canada,June2-5,2007.GuestExpert,“1stWorldCongressonInterventionalTherapiesforType2Diabetes,”NewYork,NewYork,September15-16,2008.VisitingProfessor,“CombinedAdult-PediatricEndocrineGrandRounds,”MattelChildrenHospitalatUCLA,DavidGeffenSchoolofMedicineatUCLA,California,September24,2008

GuestSpeaker,“ShanghaiInternationalMedicalDevelopmentForumonFamilyMedicine2012,”Shanghai,China,May10-11,2012.

DistinguishedInternationalFaculty,“8thInternationalSymposiaonDiabetes2013”,Delhi,Kolkata,Chennai,Mumbai,India,January18-26,2013.

InvitedLecturer,AmericanAssociationofClinicalEndocrinologists(AACE)PhilippinesChapter,Cebu,Philippines,August1-3,2013.InvitedLecturer,TokyoMedicalandDentalUniversity,Tokyo,Japan,December10,2013.InvitedLecturer,DepartmentofMedicineGrandRoundsatMountSinaiMedicalCenter,“PCOSUpdate2014”,NewYork,January7,2014.InvitedLecturer,CombinedMKSCC/CornellEndocrineGrandRounds,“Insulinandtheovary:Update2014”,NewYork,January8,2014.InvitedLecturer,4thInternationalCongressofGynaecologyandObstetrics2016.Topic:InsulinandtheOvary:Update2016.Barcelona,Spain,May28-30,2016.SessionChair,“Polycysticovarysyndrome,”4thInternationalCongressofGynaecologyandObstetrics2016,Barcelona,Spain,May28-30,2016.InvitedLecturer,“Pathwaytowellness:Men’shealthpanelandhealthfair,”TheUnitedNations,NewYork,NY,August29,2017.InvitedSpeaker,“HealthandSocietyRoundtable”HumanRightsConferenceforPride,SUNYGlobalCenter,NewYork,NY,June14,2018.

LEONIDPORETSKY,M.D.

12

InvitedLecturer,“AdvancesinSpecialtyCare”,multidisciplinarysymposium,Bermuda(U.K.),September15,2018.PanelLeader/Moderator,“TransgenderandSociety,”TheUnitedNations,NewYork,NY,June28,2019.

PROFESSIONALSOCIETIES:1985 AmericanDiabetesAssociation1987 InternationalDiabetesFederation AmericanAssociationfortheAdvancementofScience1988 TheEndocrineSociety1994 AmericanAssociationofClinicalEndocrinologists1996 MetropolitanDiabetesSociety,foundingBoardmemberBESTDOCTORSLISTINGS:NewYorkMagazineTheNewYorkTimesMagazineU.S.NewsandWorldReportCastleConnollyMedicalLimitedRECENTHONORSANDAWARDS:April2,2018 2018RosieAwardforadvancingdiversity;AmasMusicalTheatre49thSeasonBenefit

EventJuly30,2019 LenoxHillHospitalwasranked#9nationallyforDiabetes&Endocrinology–USNews

andWorldReport,July30,2019.ORIGINALPEER-REVIEWEDPUBLICATIONS:1. PoretskyL.Somepeculiaritiesofdiabetesmellitusinyoungobesepatients.InV.MenschikoffandV.

Spesivtseva,Eds.,ProblemsofDiabetology,Moscow,50-511977.

2. PoretskyL,SmithD,SeibelM,PazianosA,MosesAC,FlierJS.SpecificInsulinbindingsitesinhumanovary.JClinEndocrinolMetab59:809-811,1984.

3. Poretsky L, Moses A. Hypoglycemia associated with Trimethoprim/Sulfamethoxazole therapy.

DiabetesCare7:508-509,1984.

4. PoretskyL,GrigorescuF,MosesAC,FlierJS.DistributionandcharacterizationoftheinsulinandIGF-1receptorsinthehumanovary.JClinEndocrinolMetab61:728-734,1985.

LEONIDPORETSKY,M.D.

13

5. PoretskyL,LeibowitzIH,FriedmanSA.Thediagnosisofmyocardialinfarctionbycomputerderivedprotocolinamunicipalhospital.Angiology36:165-170,1985.

6. Poretsky L, Garber J, Kleefield J. Primary amenorrhea and pseudoprolactinoma in a patientwith

primary hypothyroidism: reversal of clinical, biochemical and radiologic abnormalities withlevothyroxine.AmJMed81:180-182,1986.

6. PepperGM,PoretskyL, Gabrilove JL,AritoneMM. Ketoconazole reverseshyperandrogenism in a

patient with insulin resistance and acanthosis nigricans. J Clin Endocrinol Metab 65:1047-1052,1987.

8. GatesGS,BayerS,SeibelM,PoretskyL,Flier JS,MosesAC. Characterizationof insulin-likegrowthfactorIbindingtohumangranulosacellsobtainedduringinvitrofertilization. JReceptorResearch7:885-902,1987.

9. KalinM,PoretskyL,SeresD,ZumoffB.Hyporeninemichypoaldosteronismassociatedwith

AcquiredImmuneDeficiencySyndrome.AmericanJMed82:1035-1038,1987.10. PoretskyL,BhargavaG,KalinM. Regulationof the insulinreceptors in thehumanovary(Invitro

studies).JClinEndocrinolMetab67:772-778,1988.11. Poretsky L, Lesvescue L, Smith D, Seibel M, Pazianos A, Hurd JK, Aretz HT, Flier JS.

Hyperandrogenism in a patient with a granulosa cell tumor and polycystic ovarian disease:characteristicsofinvitrosteroidogenesis.TheJournalReproductiveMed33:377-381,1988.

12. PoretskyL,GloverB,LaumasV,KalinM,DunaifA.Theeffectsofexperimentalhyperinsulinemiaon

steroid secretion, ovarian 125-I-insulin binding and ovarian 125-I-insulin-like growth factor Ibindingintherat.Endocrinology122:581-585,1988.

13. SingerF,HorlickM,PoretskyL.Recoveryofbeta-cellfunctionpostpartuminapatientwithinsulin-

dependentdiabetesmellitus.NewYorkStateJournalofMedicine9:496-498,1988.14. BhargavaG,PoretskyL,DenmanH, JandorekR,MillerLK. Hormonallyactive long-termcultureof

humanovariancells:initialcharacterization.Metabolism38:195-196,1989.15. Singer F, Bhargava G, Poretsky L. Persistent insulin resistance after normalization of androgen

levelsinawomanwithcongenitaladrenalhyperplasia.JournalReproductiveMedicine34:921-922,1989.

16. Poretsky L, Bhargava G, Levitan E. Type I insulin-like growth factor receptors in human ovarian

stroma.HormoneResearch33:22-26,1990.17. PoretskyL,BhargavaG,SaketosM,DunaifA.Regulationofhumanovarianinsulinreceptorsin-vivo.

Metabolism39:161-166,1990.18. Zumoff B, Miller L, Poretsky L, Levit C. Miller E, Heinz U, Denman H, Jandorek R, Rosenfeld R.

Subnormalfollicular-phaseserumprogesteronelevelsandelevatedfollicular-phaseserumestradiollevelsinyoungwomenwithinsulindependentdiabetes.Steroids55:560-564,1990.

LEONIDPORETSKY,M.D.

14

19. Novick D, Joseph H, Croxson S, Salsitz E, Wang G, Richman B, Poretsky L, Keefe J, Whimbey E.Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitatedmethadonemaintenancepatients.ArchIntMed150:97-99,1990.

20. Battan R, Mariuz P, Raviglione MD, Sabatini MT, Mullen MP, Poretsky L. Pneumocystitis carinii

infection of the thyroid in a hypothyroid patient with AIDS: Diagnosis by fine needle aspirationbiopsy.JClinEndocrinologyMetab72:724-726,1991.

21. Poretsky L, Clemons J, Bogovich K. Hyperinsulinemia and human chorionic gonadotropin

synergisticallypromotethegrowthofovarianfollicularcystsinrats.Metabolism41:903-910,1992.22. GochuJ,PiperB,MontanaJ,ParkHS,PoretskyL.Lymphomaofthethyroidmimickingthyroiditisin

apatientwiththeAcquiredImmuneDeficiencySyndrome.JEndocrinolInvest17:279-282,1994.23. SorbaraLR,TangZ,CamaA,XiaJ,SchenkerE,KohanskiRA,PoretskyL,KollerE,TaylorSI,DunaifA.

Absenceof insulinreceptorgenemutations in three insulin-resistantwomenwithpolycysticovarysyndrome.Metabolism43:1568-74,1994.

24. Ramaprasad S, Poretsky L. Life-threatening hyponatemia due to the syndrome of inappropriate

secretion of antidiuretic hormone (SIADH) in a patient with Miller Fisher Syndrome. EndocrinePractice1:64-66,1995.

25. Rubio SI, Naha KK, Poretsky L. Coexistence of diabetes and phosphofructokinase deficiency.

EndocrinePractice2:100-102,1996.26. PoretskyL,ChandrasekherYA,GiudiceLC,BaiC,H-LLiu,RosenwaksZ. Insulinreceptormediates

inhibitory effect of insulin, but not of insulin-like growth factor (IGF)-I, on IGF binding protein 1(IGFBP-1)productioninhumangranulosacells.JClinEndocrinolMetab81:493-496,1996.

27. PoretskyL,ChunB,LiuHC,RosenwaksZ. Insulin-likegrowthfactorII(IGF-II)inhibitsinsulin-like

growth factor binding protein I (IGFBP-1) production in luteinized human granulosa cells with apotencysimilartoinsulin-likegrowthfactorI(IGF-I)andhigherthaninsulin.JClinEndocrinolMetab81:3412-3414,1996.

28. RubioSI,Sauer-PlewinskiT,SabatiniM,PoretskyL. Kikuchi’sdiseaseassociatedwithHashimoto’s

thyroiditis.JEndocrinolInvest19:136-137,1996.29. Stolarczyk R, Laufer I, Poretsky L. Absence of acanthosis nigricans in a patient with the Type B

syndromeofinsulinresistanceandpreexistingdiabetes.DiabetesCare19:885-886,1996.30. Koproski J, Pretto Z, Poretsky L. Effects of an intervention by a diabetes team in hospitalized

patientswithdiabetes.DiabetesCare20:1553-1555,1997.31. StolyarczykR,RubioS,SmolyarD,Young I,PoretskyL.24hrurinary freecortisol inpatientswith

acquiredimmunedeficiencysyndrome.Metabolism47:690-694,1998.32. PoretskyL,PrettoZ,KoproskiJ.,Lengthofstayonadiabetesclusterunit.EndocrinePractice5:66-

68,1999.33. BogovichK, Clemons J,PoretskyL. Insulinhas a biphasic effect on the ability of human chorionic

gonadotropintoinduceovariancystsintherat.Metabolism48:995-1002,1999.

LEONIDPORETSKY,M.D.

15

34. FerrandoSJ,RabkinJG,PoretskyL.Dehydroepiandrosteronesulfate(DHEAS)andtestosterone:RelationtoHIVillnessstageandprogressionoveroneyear.JournalofAcquiredImmuneDeficiencySyndromesandHumanRetrovirology22:146-154,1999.35.DamarioM,BogovichK,LiuHC,RosenwaksZ,PoretskyL.SynergisticeffectsofIGF-Iandhumanchorionicgonadotropinintheratovary.Metabolism49:314-320,2000.36. Aronoff S, Rosenblatt S, Braithwaite S, Egan JW,MathisenAL, SchneiderRL, ThePioglitazone001

StudyGroup. Pioglitazonehydrochloridemonotherapyimprovesglycemiccontrol inthetreatmentofpatientswithtype2diabetes.DiabetesCare23:1605-1611,2000.

37. PoretskyL, LesserM,BrillonD. Lackofpostprandial leptinpeaks inpatientswith type2diabetes

MelliltusDiabetes,ObesityandMetabolism3:105-111,2001.38. Poretsky L, Seto-Young D, Shrestha A, Dhillon S, Mirjany M, Liu, H-C, Yih M, Rosenwaks Z.

Phosphatidyl-inositol-3 (PI-3)-kinase-independent insulin action pathway(s) in the human ovary. JClinEndocrinolMetab86:3115-3119,2001.

39. Tolentino M, Ferenczi A, Ronen L, Poretsky L. Combination of gemfibrozil and orlistat in the

treatmentof combinedhyperlipidemiawithpredominanthypertriglyceridemia. EndocrinePractice8:3,208-212,2002.

40. SmolyarD,LandmanR,PoretskyL,YoungI.Comparisonof1µgand250µgACTHstimulationtests

fortheevaluationofadrenalfunctioninpatientswithAIDS.Metabolism52:647-651,2003.41. Seto-YoungD,ZajacJ,LiuHC,RosenwaksZ,PoretskyL.Theroleofmitogen-activatedproteinkinase

ininsulinandinsulin-likegrowthfactorI(IGF-1)signalingcascadesforprogesteroneandIGF-bindingprotein-1productioninhumangranulosacell.JClinEndocrinolMetab88:3385-3391,2003.

42. ZinmanB,KahnSE,HaffnerSM,O’NeillMC,HeiseMA,FreedMI,ADOPTStudyGroup. Phenotypic

characteristics of GAD antibody-positive recently diagnosed patientswith type 2 diabetes inNorthAmericaandEurope.Diabetes53:3193-3200,2004.

43.SalehiM,HouldenH,SheikhA,PoretskyL.Thediagnosisofadrenalinsufficiencyinapatientwith

AllgrovesyndromeandanovelmutationintheALADINgene.Metabolism54:200-205,2005.

44. Seto-YoungD,PaliouM,Schlosser J,AvtanskiD,ParkA,PatelP,HolcombK,ChangP,PoretskyL.Thiazolidinedione action in the human ovary: direct effects on steroidogenesis and insulin-likegrowthfactorbindingprotein-1(IGFBP-1)production.JClinEndocrinolMetab90:6099-6105,2005.

45. Seto-YoungD,LeonardiO,ParkA,HolcombK,SalehiM,ChangP,YihM,Rosenwaks Z, Poretsky L.

Hormonally active non-transformed human ovarian cell culture from oophorectomy specimens:methodsofdevelopmentandinitialcharacterization.HormoneResearch64:238-247,2005.

46. Poretsky L, Brillon DJ, Ferrando S, Chiu J, McElhineyM, Ferenczi A, Sison CP, Haller I, Rabkin J.

Endocrineeffectsoforaldehydroepiandrosterone(DHEA)inmenwithHIVinfection:Aprospectiverandomizeddouble-blindplacebo-controlledtrial.Metabolism55:858-870,2006.

LEONIDPORETSKY,M.D.

16

47. BrillonDJ,SisonCP,SalbeAD,PoretskyL.Reproducibiltyofaglycemicresponsetomixed mealsintype2diabetesmellitus.HormoneandMetabolicResearch38:536-542,2006.48. KahnSE,ZinmanB,HaffnerSM,O’NeillMC,HeiseMA,KravitzBG,ADOPTStudyGroup.Obesity

isamajordeterminantoftheassociationofc-reactiveproteinlevelsandthemetabolicsyndromeintype2diabetes.Diabetes55:2357-2364,2006.

49. KahnSE,HaffnerSM,HeiseMA,HermanWH,HolmanRR,ADOPTStudyGroup.Glycemicdurabilityofrosiglitazone,metformin,orglyburidemonotherapy.NEJM355:2427-2443,2006.

50. Seto-Young D, Avtanski D, Strizhevsky M, Parikh G, Patel P, Kaplun J, Holcomb K, Rosenwaks Z,

Poretsky L. Interactions among peroxisome proliferator activated receptor-γ, insulin signalingpathways,andsterodogenicacuteregulatoryproteininhumanovariancells.JClinEndocrinolMetab92:2232-2239,2007.

51.MartinezR,PoretskyL.Casestudy.Insulin2:144-145,2007.52. MartinezR,PoretskyL.Casestudyresponse.Insulin2:190-191,200753. Gurevich Y, Poretsky L. Possible prevention of hungry bone syndrome by preoperative use of

pamidronate.Otolaryngology-HeadandNeckSurgery,138:403-404,2008.

54. Kahn SE, ZinmanB, Lachin JM,Haffner SM,HermanWH,HolmanRR, Kravitz BG, YuD,HeiseMA,AftringRP,VibertiG,ADOPTStudyGroup.Rosiglitazone-associatedfracturesintype2diabetes:ananalysisfromadiabetesoutcomeprogressiontrial(ADOPT).DiabetesCare31:845-851,2008.

55. PoretskyL,SongL,BrillonDJ,FerrandoS,ChiuJ,McElhineyM,FerencziA,SisonC,HallerI,RabkinJ.MetabolicandhormonaleffectsoforalDHEAinpremenopausalwomenwithHIVinfection.HormoneandMetabolicResearch41:244-249,2009.

56. KahnSE,HaffnerSM,VibertyG,HermanWH,LachinJM,KravitzBG,YuD,Paul,G,HolmanRR,ZinmanB,ADOPTStudyGroup. RosiglitazonedecreasesC-Reactiveproteintoagreaterextentrelativetoglyburideandmetforminover4yearsdespitegreaterweightgain.DiabetesCare33:177-183,2010.

57. ZinmanB,HaffnerSM,HermanWH,HolmanRR,LachinJM,Kravitz,BG,PaulG,JonesNP,AftringRP,VibertiG,KahnSE,ADOPTStudyGroup. Effectofrosiglitazone,metformin,andglyburideonbonebiomarkersinpatientswithtype2diabetes.JClinEndocrinolMetab95:134-142,2010.

58. HomelPD,KahnSE,JonesNP,NoronhaD,Beck-NielsenH,VibertiG;ADOPTStudyGroup;RECORD

SteeringCommittee.ExperienceofmalignancieswithoralglucoseloweringdrugsintherandomizedcontrolledADOPT(ADiabetesOutcomeProgressionTrial)andRECORD(RosiglitazoneEvaluatedforCardiovascular Outcomes and Regulationof Glycaemia in Diabetes) clinical trials. Diabetologia53:1838-1845,2010.

59. PatelP,PoretskyL,LiaoE.LackofeffectofsubtherapeuticvitaminDtreatmentonglycemic

andlipidparameters inType2diabetes: ApilotProspectiverandomizedtrial. JDiabetes2:36-40,2010.

LEONIDPORETSKY,M.D.

17

60. ParikhG,VaradinovaM,SuwandhiP,ArakiT,RosenwaksZ,PoretskyL, Seto-YoungD. VitaminDregulatessteroidogenesisand insulin-likegrowth factorbindingprotein-1 (IGFBP-1)production inhumanovariancells.HormMetabRes42:754-757,2010.

61. Seto-YoungD,AvtanskiD,ParikhG,SuwandhiP,StrizhevskyM,ArakiT,RosenwaksZ,PoretskyL.Rosiglitazone and pioglitazone inhibit estrogen synthesis in human granulosa cells by interferingwithandrogenbindingtoaromatase.HormMetabRes43:250-256,2011.

62. Seto-Young D, Avtanski D, VaradinovaM, Park A, Suwandhi P, Parikh G,Poretsky L. Differential

roles of MAPK-Erk1/2 and MAPK-p38 in insulin or insulin-like growth factor-I (IGF-I) signalingpathwaysforprogesteroneproductioninhumanovariancells.HormMetabRes43:386-390,2011.

63. AbelevZ,SethA,PatelR,GoldsteinS,BogunM,PaliouM,SchlosserJ,Homel P, Busta A, Seto-Young

D, TranbaughR,Poretsky L. Continuous Insulin Infusion (CII) is associatedwith a reduced post-surgical lengthofstay(LOS),butnotthecomplicationrate, inpatientswithdiabetesmellitus(DM)undergoingCoronaryArteryBypassGraft(CABG).JEndocrInvest,34:770-774,2011.

64. Araki T, Varadinova M, Goldman M, Rosenwaks Z, Poretsky L, Seto-Young D. Rosiglitazone and

pioglitazone alter aromatase kinetic properties in human granulose cells. PPAR Research.doi:10.1155/2011/926438,2011.

65. Seth A, Sy V, Pareek A, Suwandhi P, Rosenwaks Z,Poretsky L, Seto-YoungD. Thiazolidinediones

(TZDs) affect osteoblast viability and biomarkers independently of the TZD effects on aromatase.HormMetabRes45:1-8,2013.

66. KimSJ,SyV,ArakiT,BabushkinN,HuangD,TanD,LiaoE,LiuG,WanS,PoretskyL,Seto-YoungD.Total adiponectin, but not inflammatory markers CRP, TNF-α, IL-6 and MCP-1, correlates withincreasingglucoseintoleranceinpregnantChinese-Americans.JDiabetes6:360-368,2014.

67. Pittas AG, Dawson-Hughes B, Sheehan P, Rosen C, Ware JH, Knowler WC, Staten M, The D2dResearchGroup.RationaleanddesignofthevitaminDandtype2diabetes(D2d)Study:Adiabetespreventionstudy.DiabetesCare.37:3227-3234,2014.

68. Yubero-Serrano EM, Woodward M, Poretsky L. Vlassara H, Striker GE, AGE-Less Study Group.

Effects of sevelamer carbonate on advanced glycation endproducts and anti-oxidant/pro-oxidantstatus inpatientswithdiabeteskidneydisease. Clinical JournalAmSocietyNephrology,10(5):59-66,2015.

69. Avtanski D, Hirth Y, Babushkin N, Sy V, Sharma D,Poretsky L, Seto-Young D. In Vitro effects of

pioglitazone on the expression of components of Wnt signaling pathway and markers of bonemineralization.HormMetabRes48:468-475,2016.

70. Poretsky L, Islam J, Avtanski D, Lin YK, Shen YL, Hirth Y, LesserM, Rosenwaks Z, Seto-Young D.Reproductiveeffectsofirisin:Initialinvitrostudies.ReprodBiol,17(3):285-288,2017.

71. Seto-YoungD, AvtanskiD, Kim SJ, SyV, Liao EP, LiuG,Wan S, LesserM,Poretsky L. Insulin-likegrowth factor (IGF)-I, IGF-bindingprotein (IGFBP)-1, and fibroblast growth factor (FGF)21 serumlevels inChinesewomenwith andwithout gestational diabetes. ClinObstetGynecolReprodMed,3(5):1-4,2017.

LEONIDPORETSKY,M.D.

18

72. SonmezH,KamboV,AvtanskiD,LutskyL,PoretskyL.Thereadmissionratesinpatientswithandwithout diabetesmellitus at an urban teaching hospital. J Diabetes Complications 31 (12), 1681-1685,2017.

73. TaylorJE,FishmanSL,MorrisM,KrymskayaM,GoldmanR,PoretskyL.Acaseofhyperthyroidismin

a patient using nutritional supplement “Survival Shield”. Endocrine Practice, DOI:10.4158/ACCR-2018-0086,2018.

74. AvtanskiD,GarciaA,CaraballoB,ThangeswaranP,MarinS,BiancoJ,LaviA,PoretskyL. Resistininducesbreastcancercellsepithelial tomesenchymaltransition(EMT)andstemnessthroughbothadenylyl cyclase-associated protein 1 (CAP1)-dependent and CAP1-independent mechanisms.Cytokine120:155-164,2019.

75. Pittas,AG,Dawson-HughesB,SheehanP,WareJH,KnowlerWC,ArodaVR,BrodskyI,CegliaL,Chhavi

C,ChatterjeeR,DesouzaC,DolorR,ForeytJ,FussP,GhaziA,HsiaDS,JohnsonKC,KashyapSR,KimS,LeBlanc ER, LewisMR, Liao E,Neff LM,Nelwon J, O’Neil P, Park J, PetersA, Phillips LS, PratleyR,RaskinP,RasouliN,RobbinsD,RosenC,VickeryEM,StatenM,etal.,fortheD2dResearchGroup*.Vitamin D Supplementation and Prevention of Type 2 Diabetes. NEJM, 381:520-530, 2019. DOI:10.1056/NEJMoa1900906.

76. AvtanskiD,ChenK,PoretskyL. Resistinandadenylylcyclase-associatedprotein1(CAP1)regulate

the expression of genes related to insulin resistance in BNL CL.2 mouse liver cells. Data in Brief25:104112,2019.

77. AvtanskiD,GarciaA,CaraballoB,ThangeswaranP,MarinS,Bianco J,LaviA,PoretskyL. Invitroeffectsofresistinonepithelialtomesenchymaltransition(EMT)inMCF-7andMDA-MB-231breastcancercellseqRT-PCRandWesternblotanalysesdata.DatainBrief25:104118,2019.

78. Chen K, Satlof L, Kothapalli U, Ziluck N, Lema M, Poretsky L, Avtanski D 2019 Basal cytokinesecretion in human breast cancer cells and non-carcinogenic breast epithelial cells – 41-cytokineMILLIPLEX assay data. Mendeley Data, V1, DOI: 10.17632/tvt8zm37w5.2,http://dx.doi.org/10.17632/tvt8zm37w5.2

79. Avtanski D, Pavlov VA, Tracey KJ, Poretsky L. Characterization of inflammation and insulinresistanceinhigh-fatdiet-inducedmaleC57BL/6Jmousemodelofobesity.AnimalModelExpMed.2019;00:1–7.https://doi.org/10.1002/ame2.12084.

80. AvtanskiD,ChenK,SatlofL,KothapalliU,ZiluckN,LemaM,PoretskyL.Effectofcobalt(II)chloride(CoCl2) treatmentoncytokinesecretionofhumanbreastcancercells. Data inBrief. Accepted forpublication.

81.ChenK,SatlofL,KothapalliU,ZiluckN,LemaM,PoretskyL,AvtanskiD.Cytokineexpressioninbreastcancercells–MILLIPLEXassaydata.DatainBrief,Submitted2019.

82.BasmanC,AvtanskiD,FishmanSL.RashidU,KodraA,ChenK,JonasR,StoffelsGJ,LesserM,

InlallD, ZiskovichK, SinghVP,PoretskyL. Glycosylatedhemoglobin, butnotAdvancedGlycationEnd Products, Predicts Severity of Coronary Artery Disease in Patients with or without Diabetes.JournalofCardiology.Submitted2019.

LEONIDPORETSKY,M.D.

19

REVIEWARTICLES,BOOKCHAPTERSandEDITORIALS:1. Flier JS, Poretsky L. Insulin allergy and insulin resistance. In Fauci AS, Lichtenstein LM, Eds.,

CurrentTherapyinAllergy,ImmunologyandRheumatology,1985-1986.Publishers:B.C.DeckerandC.V.MosbyP.136-140,1985.

2. PoretskyL,KalinM.Thegonadotropicfunctionofinsulin.EndocrineReviews8:132-141,1987.

3. PoretskyL,KalinM.Diabetesandovariandysfunction:whatistheconnection?TheFemalePatient

13:112-132,1988.4. Poretsky L. Insulin receptor - a potential target for pharmacological agents. Drug News and

Perspectives2:6,325-328,1989.

7. PoretskyL,MaranA,ZumoffB.EndocrinologicalandmetabolicmanifestationsofAIDS.MountSinaiJournalofMedicine57:236-241,1990.

8. Poretsky L. On the paradox of insulin-induced hyperandrogenism in insulin resistant states.

Endocrine Reviews 12:3-13, 1991. Reprinted in The Endocrine Pancreas, Insulin Action andDiabetes.ANegro-VilarandL.E.Underwood,Eds.EndocrineReviewMonographs,EndocrineSocietyPress,Bethesda,MD2:115-124,1994.

8. PoretskyL. Role of insulin resistance in thepathogenesis of thepolycystic ovaries syndrome. In:Ovarian Endocrinopathies. R. Schats, J. Schoemaker, Eds; Parthenon Publishing, London, 169-177,1994.

9. PoretskyL. Insulin resistance andhyperandrogenism:Update1994. InTheEndocrinePancreas,

InsulinActionandDiabetes:A.Negro-VilarandL.E.Underwood,Eds.EndocrineReviewsMonograph;EndocrineSocietyPress,Bethesda,MD,2:125-129,1994.

10. Poretsky L, Piper B. Dual defect hypothesis of the polycystic ovaries syndrome. Obstetrics and

Gynecology84:613-621,1994.11. PoretskyL,CanS,ZumoffB.Testiculardysfunctioninhumanimmunodeficiencyvirusinfectedmen.

Metabolism,Vol44,7:946-953,1995.12. KoproskiJ,PrettoZ,PoretskyL.Hospitalmanagementofpatientswithdiabetesinpost-DCCTera.

PracticalDiabetology14:2-7,1995.

13. PoretskyL,PastorC.Physicianreviewersandconflictofinterest,Editorial.TheEndocrinologist:5:85-86,1995.

14. PoretskyL,CataldoN,RosenwaksZ,GuidiceL.Insulin-relatedovarianregulatorysysteminhealth

anddisease.EndocrineReviews20:535-582,1999.15. PoretskyL.Polycysticovarysyndrome(bookreview).JClinEndocrinolMetab86:2402,2001.16.BloomgardenZ,FutterweitW,PoretskyL.Useofinsulinsensitizingagentsinpatients withpolycysticovarysyndrome.EndocrinePractice7:279-286,2001.

LEONIDPORETSKY,M.D.

20

17. Tolentino M, Zweig, SB, Poretsky L. Polycystic ovarian syndrome. In: “Principles of Diabetes

Mellitus”,pp701-721,L.Poretsky,Ed.KluwerAcademicPublishing,Boston,MA,2002.18. ZajacJ,ShresthaA,PoretskyL.Themaineventsinthehistoryofdiabetesmellitus.In:“Principlesof

DiabetesMellitus”,pp19-37,L.Poretsky,Ed.KluwerAcademicPublishing,Boston,MA,2002.19. SalehiM,Bravo-VeraR,SheikhA,GoullerA,PoretskyL.Obesityinpolycysticovary

syndrome: Two diseases or one? Turkish Journal of Endocrinology and Metabolism 4:149-157,2003.

20. SalehiM,Bravo-VeraR,SheikhA,GoullerA,PoretskyL.Pathogenesisofpolycysticovarysyndrome:Whatistheroleofobesity?Metabolism53:358-376,2004.

21. LiaoEP,PoretskyL.Polycysticovarysyndromeanditsmetaboliccomplications.

In"ObesityandDiabetes",pp255-276.C.Mantzoros,Ed.,HumanaPress,Totowa,NJ,2006.

22. PoretskyL.Polycysticovarysyndrome:Increasedorpreservedovariansensitivitytoinsulin?JClinEndocrinolMetab91:2859-2860,2006.

23. LevineP,KaplunJ,ShavelsonD,PoretskyL. Thepre-Charcotfoot:AnewclinicalentitytopreventCharcotjointdisease.PracticalDiabetology25:24-28,2006.

24. AlfonsoB,LiaoEP,BustaA,PoretskyL.TheroleofvitaminDindiabetesmellitus—anewfieldofknowledgepoisedforD-velopment.Diabetes/MetabolismResearchandReviews25:417-419,2009.

25. Zweig,SB,TolentinoMC,StrizhevskyM,PoretskyL.Polycysticovarysyndrome.In:“Principlesof

DiabetesMellitus”,pp515-530,2ndedition,L.Poretsky,Ed.Springer,NewYork,2010.

26. Zajac J, Shrestha A, Patel P, Poretsky L. The main events in the history of diabetes mellitus. In:“PrinciplesofDiabetesMellitus”,pp3-16,2ndedition,L.Poretsky,Ed.Springer,NewYork,2010.

27. BrassBJ,AbelevZ,LiaoEP,PoretskyL.EndocrinePancreas.In:“PrinciplesofDiabetesMellitus”,pp37-55,2ndedition,L.Poretsky,Ed.Springer,NewYork,2010.

28. PoretskyL. PrefaceII. In: “PrinciplesofDiabetesMellitus”,2ndedition,L.Poretsky,Ed. Springer,

NewYork,2010.

29. Romero CM, Liao EP, Zumoff B, Poretsky L. Dehydroepiandrosterone (DHEA) in HumanImmunodeficiencyVirusInfection:PrognosticandTherapeuticAspects.In:“DHEAinHumanHealthandAging”,pp195-205.R.Watson,Ed.,CRCPress,BocaRaton,FL,2011.

30. Araki T, Abdallah R, Rosenwaks Z,Poretsky L. Achieving a successful pregnancy inwomenwith

PCOS.EndocrinologyandMetabolismClinicsofNorthAmerica,40:865-894,2011.31. AlfonsoB,PoretskyL,BustaA.RoleofVitaminDinthepathogenesisandtherapyoftype1

diabetesmellitus. In: “Type1Diabetes/Book3”,CPLiu,Ed.,InTechOpenAccessPublisher,Rijeka,Croatia,2011.

32. PoretskyL.“StopthesovietizationofAmericanmedicine,”Op/Ed,Forbes.com,July3,2012.

LEONIDPORETSKY,M.D.

21

33.PoretskyL.Lookingbeyondovernutritionforcausesofepidemicmetabolicdisease.Proceedingsof

theNationalAcademyofSciencesoftheUnitedStatesofAmerica.39:15537-15538,2012.34. Poretsky L. The sovietization of American medicine: Notes from the front lines. Journal of AmericanPhysiciansandSurgeons,18(2),2:50-54,2013.35.LiaoE,PoretskyL.Whyfocusoncomplications?EndocrinologyandMetabolismClinicsofNorth America,42:657-1014,2013.36. NandiA,PoretskyL.Diabetesandthefemalereproductivesystem.EndocrinologyandMetabolism

ClinicsofNorthAmerica,42:915-946,2013.37. LiaoE,BustaA,PareekA,PoretskyL.Newapproachtopreventingandtreatingdiabetes mellitus:

Focusonadvancedglycationendproducts(AGE). In: “Frontiers inclinicaldrugresearch-diabetesandobesity”,Atta-Ur-Rahman,FRS,Ed.,pp33-36,BenthamScience,TheNetherlands,2014.

38. Liao EP, Poretsky L. Associated conditions: Why are they important? Endocrinology and

MetabolismClinicsofNorthAmerica,43:1,xvii-xviii,2014.39. Nandi A, Chen Z, Patel R, Poretsky L. Polycystic ovary syndrome. Endocrinology and MetabolismClinicsofNorthAmerica,43:1,123-147,2014.40. Nandi A, Sinha N, Ong W, Sonmez E, Poretsky L. Is there a role for Vitamin D in human

reproduction?HormMolBiolClinInvest,25(1):15-28,2016.

41. SonmezH,KamboV,TahaR,PoretskyL.Reducinghospitalreadmissionsinpatientswithdiabetes:Developingbetterstrategies.EndocrPract,22:9,1134-1136,2016.DOI:10.4158/EP161315.CO.

42. Goldman R, Zajac J, Shrestha A, Patel P,Poretsky L. The main events in the history of diabetes

mellitus. In: “Principles of DiabetesMellitus”, pp 3-19, 3rd edition, L. Poretsky, Ed. Springer, NewYork,2017.

43. LiaoEP,PoretskyL.EndocrinePancreas.In:“PrinciplesofDiabetesMellitus”,pp43-55,3rdedition,

L.Poretsky,Ed.Springer,NewYork,2017.44. Sood M, Zweig S, Tolentino M, Strizhevsky M, Poretsky L. Polycystic ovary syndrome. In:

“PrinciplesofDiabetesMellitus”,pp659-677,3rdedition,L.Poretsky,Ed.Springer,NewYork,2017.45. FishmanSL,SonmezH,SinghV,AvtanskiD,NandiA,MabagosG,PoretskyL. “AdvancedGlycation

End-Products and coronary artery disease in patients with and without diabetes: A review.”MolecularMedicine,24:59,2018.DOI:10.1186/s10020-018-0060-3.

46. AvtanskiD,PoretskyL.Phyto-polyphenolsaspotentialinhibitorsofbreastcancermetastasis.

MolecularMedicine.MolecularMedicine24(1):29-45,2018.47. ColonD,GoldsteinS,PoretskyL.Resourcesfortransgenderindividuals:Transgenderorganizations

andservices. In: “Transgendermedicine–Amultidisciplinaryapproach”,pp377-462,L.PoretskyandW.Hembreeeditors,Springer,NewYork,2019.

LEONIDPORETSKY,M.D.

22

48. FishmanSL,PaliouM,PoretskyL,HembreeW.Endocrinecareoftransgenderadults.In:

“Transgendermedicine–Amultidisciplinaryapproach”,pp143-163,L.PoretskyandW.Hembreeeditors,Springer,NewYork,2019.

BOOKS:1. Principlesofdiabetesmellitus,1stedition.L.Poretsky,editor.KluwerAcademicPublishing,Boston,

MA,2002.

2. Principlesofdiabetesmellitus,2ndedition.L.Poretsky,editor.Springer,NewYork,2010.3. Conciseguidetodiabetes.L.Poretsky,editor.Springer,NewYork,2012.

4. Principlesofdiabetesmellitus,3rdedition.L.Poretsky,editor.Springer,NewYork,2017.

5. Transgendermedicine-Amultidisciplinaryapproach,1stedition.L.PoretskyandW.Hembree

editors.Springer,NewYork,2019.

ABSTRACTSPRESENTEDATNATIONALANDINTERNATIONALMEETINGS:1. Poretsky L, SmithD, SeibelM,Moses AC, Flier JS. Specific insulin receptors in the human ovary:

possible mediators of hyperandrogenism in insulin resistant states. Proceedings of the 23rdScientificMeetingontheMass.AffiliateAmericanDiabetesAssociation,Boston,Mass.,1984p.16.

2. PoretskyL,GrigorescuF,FlierJS.InsulinbutnotIGF-Ireceptorsarewidelydistributedinthe

humanovaries.Presentedatthe67thAnnualMeetingoftheAmericanEndocrineSociety,A814,p.204,1985.

3. SeibelMM,PoretskyL,GrigorescuF,MosesAC,FlierJS.Thedistributionofinsulinreceptorsinthehuman ovary. Presented at the 41st AnnualMeeting of the American Fertility Society, A76, p.42,1985.

4. KalinM,PoretskyL,SeresD,ZumoffB.Hyporeninemichypoaldosteronismassociatedwithacquiredimmune deficiency syndrome. Presented at the 68th Annual Meeting of the American EndocrineSociety,A680,p.201,1986.

5. KalinM.PoretskyL,SeersD,ZumoffB.Hyporeninemichypoaldosteronismassociatedwithacquiredimmune deficiency syndrome. Presented at the 68th annual meeting of the American College ofPhysicians,A26April2-5,1987.

6. SingerF,HorlickM,PoretskyL.RecoveryofBeta-CellFunctionPostpartuminanInsulinDependent

Diabetic.Materialsofthe47thAnnualMeetingoftheAmericanDiabetesAssociation,A823June7-9,1987.

7. PoretskyL,GloverB,LaumasV,KalinM,DunaifA.Regulationofovarianinsulinreceptor,IGF-1receptors,andaromataseactivitybyexperimentalhyperinsulinemiainvivoClinicalResearch.35:401A,1987.

LEONIDPORETSKY,M.D.

23

8. PoretskyL, BhargavaG,KalinMF,Wolf S, JimenesGJS, SolisOG. In vitro regulation of Insulin

receptors in the human ovary. A686 70th AnnualMeeting of the Endocrine Society; NewOrleans,1988.

9. Singer F, Poretsky L. Insulin Resistance persists after normalization of androgens in congenital

adrenalhyperplasia.48thAnnualMeetingoftheAmericanDiabetesAssociation,A579,NewOrleans,June11-14,1988.

10. PoretskyL, BhargavaG, KalinMF,Wolf S, JimenesGJS, SolisOG. In vitro regulation of insulin

receptorsinthehumanovary.13thInternationalDiabetesFederationCongress,Sydney,Australia,A002-015,1988.

11. PoretskyL,BhargavaG,SaketosM,DunaifA.Regulationofhumanovarianinsulinreceptorsin-vivo.

Presentedatthe71stAnnualMeetingoftheEndocrineSociety,SeattleWA,A894,1989.12. Poretsky L, Clemons J, Bogovich K. Effects of hyperinsulinemia on the induction of rat ovarian

follicular cysts by human chorionic gonadotropin. 73rd Annual Meeting of the Endocrine Society,WashingtonDC,A354,1991.

13. KoproskiJ,PrettoZ,PoretskyL.TheeffectoftheDiabeticUnitandtheDiabetesTeamonthelength

ofstayofpatientswithdiabetesinthehospital.Presentedatthe54thAnnualAmericanDiabetesAssociationMeeting,NewOrleans,LA,A97,1994.

14. ChandrasekherYA,GiudiceLC,BaiC,LiuH-L,RosenwaksZ,PoretskyL.Insulinandinsulin-like

growthfactorI(IGF-I)inhibitIGFbindingproteinI(IGFBP-I)productionbyhumangranulosa-lutealcells(hGCs).AmericanFertilitySocietyMeeting,p.159,1994.

15. PoretskyL.Insulinresistanceandthepolycysticovarysyndrome.StraubPacificHealthFoundation

Symposium,Honolulu,HI,November3-4,1994.

16. KoproskiJ,PrettoZ,PoretskyL. Theeffectsofdiabetesinitiativeinanacutecaresetting.GreaterNewYorkHospitalFoundation,Inc.AndUnitedHospitalFundofNewYork,1994AnnualSymposiumonHealthServicesResearch,NewYork,NY,November,1994.

17. PoretskyL, ChandrasekherYA,BaiC, LiuHC,RosenwaksZ, SiddleK,GiudiceL. Insulin and IGF-I

inhibit IGF binding protein I (IGFBP-I) production in human granulosa cells via their respectivereceptors.TheEndocrineSocietyMeeting,Washington,DC,P3-219,1995.

18. Koproski J, Pretto Z, Poretsky L. Effects of the multidisciplinary approach to patients with

diabetes mellitus in an acute care teaching hospital. American Diabetes Association Meeting,President’spostersession,Atlanta,GA,A596,1995.

19. ClarkC.R.,KimE.,ChandrasekherY.A.,MartinaN.A,PoretskyL,GiudiceL.D.Twodistinctisoforms

of IGFBP-1 are found in luteinized granulosa cell conditioned media from IVF patients. 10thInternationalCongressofEndocrinology,SanFrancisco,CA,P3-394,1996.

20. BogovichK.,Clemons,PoretskyL.Theeffectsofincreasingdosesofhumanchorionicgonadotropin

and insulin on ovarian morphology and plasma sex steroid concentrations in the rat. 10thInternationalCongressofEndocrinology,SanFrancisco,CA,P3-317,1996.

LEONIDPORETSKY,M.D.

24

21. ChunB.,LiuH.C.,RosenwaksZ.,PoretskyL.Insulin-likegrowthfactorII(IGF-II)inhibitsinsulin-likegrowthfactorbindingproteinII(IGFBP-I)productioninhumangranulosecells(HGC)withthepotencysimilartoIGF-Iandhigherthaninsulin.10thInternationalCongressofEndocrinology,SanFrancisco,CA,P2-256,1996.

22. DamarioM.,Bogovich,LiuH.C,MandelL,RosenwaksZ,PoretskyL.Evidencethatinsulin-like

growth factor I (IGF-I) acts synergistically with human chorionic gonadotropin (hCG) for theinduction of large ovarian cysts in the rat. 10th International Congress of Endocrinology, SanFrancisco,CA,P1-303,1996.

23. Bogovich K , Wheeler B, Russell R , Rosenwaks Z,Poretsky L. Induction of ovarian cysts in theZuckerrat.TheEndocrineSocietyMeeting,Minneapolis,MNP-389,1997.

24. Stolarczyk R, Rubio S, Young I,Poretsky L. 24 hr urinary free cortisol levels and plasma cortisol

responsestoACTHinAIDS.TheEndocrineSocietyMeeting,Minneapolis,MN,P-309,1997.25. YahampathN,PatelR,RaoR,FarkouhT,SalbeA,PoretskyL.Glycemicindexofamixedmeal(GIMM)

inNIDDM. 57thAnnualMeetingoftheAmericanDiabetesAssociation,A-1107,P289A,BostonMA,1997.

26. ManzoorA,LeeE,BrillonD,SalbeA,PoretskyL. Glycemic indexofamixedmeal (GIMM) in type

2DM.58thAnnualmeetingoftheAmericanDiabetesAssociation,0327,PA-84,Chicago,1998.27. Poretsky L, Brillon D. Circulating leptin levels do not change postprandially in patients with type 2 diabetes mellitus (DM) who are not on insulin therapy. 80th Annual Meeting of the EndocrineSocietyP3-389,P466,NewOrleans1998.29. SmolyarD,LandmanR,PoretskyL,YoungI.Comparisonof1µgACTHstimulationtestsforthe

evaluationofadrenalfunctioninpatientswithAIDS.80thAnnualMeetingoftheEndocrineSociety,P2-389,P332,NewOrleans,1998.

30. Bogovich K, Bissada M, ReidWP, Wheeler BB, Rosenwaks Z, Poretsky L. Differences in ovarianresponses of lean and obese adult Zucker rats to prolonged stimulation by ubovulatory doses ofhumanchorionicgonadotropin(hCG):potentialeffectofhyperinsulinemiaonthegrowthofovariancysts.81stAnnualEndocrineSocietyMeeting,OR11-2SanDiego,1999.

31. PoretskyL,AndersonR,KynerJandMertenJ.Incidenceofhypoglycemia(fingerstickbloodglucose<50mg/dL)withmetformin/glyburide. Abstract 494. 60th AnnualMeeting of AmericanDiabetesAssociation,SanAntonio,Texas,June9-13th,2000.

32. Poretsky L,Mooradian A, Buse J, Kyner J andHenryD. Effect ofmetformin/glyburide tablets onlacticacidinpatientswithtype2diabetes.Abstract1523.60thAnnualMeetingofAmericanDiabetesAssociation,SanAntonio,Texas,June9-13th,2000.

33. Poretsky L, Dhillon S, Yih M, Liu HC, and Rosenwaks Z. Evidence for a PI-3 kinase independentinsulinactionpathwayintheovary,Abstract#564,82ndAnnualEndocrineSocietyMeeting,Toronto,Canada,June21-24,2000.

LEONIDPORETSKY,M.D.

25

34. Tolentino M, Poretsky L. Combination of Gemfibrozil and Orlistat in the treatment of severehypertriglyceridemia in a non-diabetic, non-obesemale. Annual Meeting, American Association ofClinicalEndocrinologists,Abstract#65,SanAntonio,Texas,May2-6,2001.

35. ZajacJ,FleckmanA,PoretskyL.Mitralandtricuspidregurgitationwithmitralvalveprolapseand

congestiveheartfailurecomplicatingGraves’disease.AnnualMeetingoftheAmericanAssociationofClinicalEndocrinologists,Abstract#49,SanAntonio,Texas,May2-6,2001.

36. PoretskyL,Seto-YoungD,ShresthaA,LiuH-C,YihM,RosenwaksZ.Humangranulosecells(HGC)possessPI-3kinase-independentinsulinactionpathway(s)whichregulateprogesteroneandIGFBP-1 production, Abstract #P2-392, 83rd Annual Meeting of the Endocrine Society, Denver, Colorado,June2-24,2001.

36. ZajacJ,BranovanD,SuslinaI,PoretskyL.Prevalenceofanti-thyro-peroxidaseAntibodies(anti-TPO-

Ab) in subjects exposed in childhood to Chernobyl fallout. Poster accepted forAnnualMeeting ofAmericanAssociationofClinicalEndocrinologists,Chicago,IL,May1-5,2002.

37. Zajac J, Salehi M, Bloomgarden B, Cohen R, Tranbaugh R, Poretsky L. Glycemic control and thelength of stay after coronary artery bypass grafting (CABG). 62nd Annual Meeting of AmericanDiabetesAssociation,704-P,SanFrancisco,CA,June14-18,2002.

38. Salehi M, Gouller A, Poretsky L. Acute leukopenia as manifestation of severe thyrotoxicosis in a

patientwithGraves’disease.Poster#P3-650,EndocrineSociety84thAnnualMeeting,SanFrancisco,CA,June19-22,2002.

39. Seto-YoungD, Zajac J, LiuHC,Rosenwaks Z,PoretskyL. Mitogen activatedprotein kinase (MAP-kinase)independenteffectofinsulininhumangranulosacells.84thAnnualMeetingoftheEndocrineSociety,P2-452,SanFrancisco,CA,June19-22,2002.

40. ZweigS,RabkinJ,FerrandoS,BrillonD,PoretskyL.EndocrineeffectsoforalDHEAadministration.

84thAnnualMeetingoftheEndocrineSociety,P1-399,SanFrancisco,CA,June19-22,2002.41. Bravo-Vera R,Poretsky L, Fleckman A. Primary hyperparathyroidism and nonmedullary thyroid

cancer. 12th Annual Meeting and Clinical Congress of the American Association of ClinicalEndocrinologists,Abstract49,SanDiego,CA,May14-18,2003.

42. SalehiM,Poretsky L. Challenging diagnosis of adrenocorticotropin insensitivity in a patientwith

Allgrove’s syndrome, 12th Annual Meeting and Clinical Congress of the American Association ofClinicalEndocrinologists,Abstract#62,SanDiego,CA,May14-18,2003.

43. FerencziA,SheikhA,PoretskyL,FleckmanA.Misleadingelevationsofurinaryfreecortisol

measurementsinthediagnosticevaluationofCushing’sSyndrome.12thAnnualMeetingandClinicalCongressoftheAmericanAssociationofClinicalEndocrinologists,Abstract#48,SanDiego,CA,May14-18,2003.

44. SalehiM,PaparsenosA,FerencziA,VecchioJ,ThakurS,CohenB,TranbaughR,LesserM,BustaA,PoretskyL.Theimpactofglycemiccontrolonthelengthofstay(LOS)aftercoronaryarterybypassgrafting surgery (CABG). Abstract #2048-PO, American Diabetes Association 63rd ScientificSession,NewOrleans,LA,June13-17,2003.

LEONIDPORETSKY,M.D.

26

45. Seto-YoungD,SalehiM,ChidakelA,ZajacJ,YihM,ChangP,PoretskyL.Initialcharacterizationofashort-termhumanovariancellculture.85thAnnualMeetingoftheEndocrineSociety,P1-692,Philadelphia,PA,June19-22,2003.

46. Seto-YoungD,ZajacJ,SalehiM,KaplunJ,FeldmanD,Hung-ChingL,RosenwaksZ,PoretskyL.TheroleofmitogenactivatedproteinkinaseininsulinandIGF-1signalingcascadesfor progesteroneandIGFBP-1productioninhumangranulosecells.85thAnnualMeetingoftheEndocrineSociety,P3-33,Philadelphia,PA,June19-22,2003.

47. FerencziA,ChiuJ,SisonC,FerrandoSJ,BrillonD,RabkinJG,PoretskyL.Metabolicandhormonal

effectsoforalDHEAinHIV+men.85thAnnualMeetingoftheEndocrineSociety,P3-615,Philadelphia,PA,June19-22,2003.

48. PaliouM,LiaoE,SchlosserJ,PoretskyL.Metformin-associatedlacticacidosis.13thAnnualMeetingandClinicalCongressoftheAmericanAssociationofClinicalEndocrinologists,Abstract#37,Boston,MA,April28-May2,2004.

49. SheikhA,SchlosserJ,Bravo-VeraR,NarasimhanG,PoretskyL.FalselylowhemoglobinA1clevelsin

a patient with diabetes mellitus, hepatitis C and HIV infection. Abstract #2405-PO, AmericanDiabetesAssociation64thAnnualMeeting,Orlando,Fl,June4-8,2004.

50. Seto-Young D, Leonardi O, Holcomb K, Kaplun J, Omry G, Park A, Levy E, SalehiM, Bravo-Vera R,

SheikhA,ChangP,PoretskyL. Characterizationofanon-transformedhumanovariancellculture:Regulationofsteroidogenesisbygonadotropinsand insulin. 86thAnnualMeetingof theEndocrineSociety,P1-250,NewOrleans,LA,June16-19,2004.

51. PaliouM,SchlosserJ,AbelevZ,PaparsenosA,Seto-YoungD,SalehiM,BustaA,PoretskyL.Impactof

intravenous insulin infusion (III) on length of stay (LOS) and post-operative complications in 438patientswithdiabetes(DM)undergoingcoronaryarterybypassgraft(CABG).86thAnnualMeetingoftheEndocrineSociety,P1-332,NewOrleans,LA,June16-19,2004.

52. ParkA,PoretskyL,HolcombK,ChangP,Seto-YoungD.Effectsofrosiglitazoneonhumanovarian

steroidogenesisandIGFBP-1productioninvitro.52ndAnnualMeetingSocietyforGynecologicInvestigation,Abstract#16,LosAngeles,CA,March2005.

53. KaplunJ,LiuL,PoretskyL.Erythrocytosisasapresentingfeatureofacromegaly.14thAnnualMeetingandClinicalCongressoftheAmericanAssociationofClinicalEndocrinologists,Abstract#742,Washington,DC,May18-22,2005.

54. PaliouM,Schlosser J,PoretskyL. Situs inversus total isassociatedwithSR⎜ gene translocation to

AM chromosome in a 46 male. 14th Annual Meeting and Clinical Congress of the AmericanAssociationofClinicalEndocrinologists,Abstract#777,Washington,DC,May18-22,2005.

55. Liu L, Kaplun J, Paliou M, Schlosser J,Poretsky L. Falsely low HgbA1c in patients with diabetes

mellitusandHIVinfection.87thAnnualMeetingoftheEndocrineSociety,P3-418,SanDiego,CA,June4-7,2005.

LEONIDPORETSKY,M.D.

27

56. Seto-YoungD,PaliouM,SchlosserJ,PatelP,ParkA,AvtanskiD,LatifW,BabarN,YeshouD,OmryG,HolcombK,PoretskyL.Peroxisomeproliferatoractivatedreceptor-γ(PPAR-γ)inhumanovariancells:ItsroleinregulationofsteroidogenesisandIGFBP-1production.87thAnnualMeetingoftheEndocrineSociety,P3-564,SanDiego,CA,June4-7,2005.

57. PaliouM,SchlosserJ,KaplunJ,SisonC,FerrandoSJ,BrillonDJ,RabkinJG,PoretskyL.MetabolicandhormonaleffectsoforalDHEAinpremenopausalwomenwithHIVinfection.87thAnnualMeetingoftheEndocrineSociety,P3-567,SanDiego,CA,June4-7,2005.

58. Saliby A, Brass B, Seto-Young D, Tranbaugh R, Poretsky L. The effects of glucose-insulin- potassium(GIK)infusionontheoutomesofcoronaryarterybypassgraft.Abstract#2157- PO, AmericanDiabetesAssociation65thAnnualMeeting,SanDiego,CA,June10-14,2005.59. PaliouM, Schlosser J,AbelevZ, SalehiM,PaparsenosA,BustaA, LesserM,PoretskyL. Impact of

glycemic control with intravenous insulin infusion (III) or subcutaneous insulin (SCI) on post-operative complications in diabetic patients undergoing coronary artery bypass graft (CABG).Abstract#2569-PO,AmericanDiabetesAssociation65thAnnualMeeting,SanDiego,CA,June10-14,2005.

60. SongL,HeringBJ,PoretskyL.Clinicalcourseofapatientwithisletcelltransplant.15thAnnualMeeting and Clinical Congress of the American Association of Clinical Endocrinologists, Abstract#319,Chicago,IL,April26-30,2006.

61. Seto-YoungD, AvtanskiD,Poretsky L. Insulin and peroxisomeproliferators- activated receptor-γsignaling in the human ovary: Basic mechanism and clinical implications. 11th InternationalSymposium on Immunology of Reproduction of the International Coordination Committee forImmunologyofReproduction,Varna,Bulgaria,June2-4,2006.

62. AvtanskiD,KaplunJ,StrizhevskyM,ParkA,PatelP,KantorY,BrownMK,DhillonS,MoosavyA,Pang

X, Akhtar MJ, Goldman M, Yeshou D, Holcomb K, Rosenwaks Z, Seto-Young D, Poretsky L.InteractionsamongPPAR-γ, insulinsignalingpathwaysandaromataseinhumanovariancells. 88thAnnualMeetingoftheEndocrineSociety,P1-397,Boston,MA,June24-27,2006.

63.AvtanskiD,ParkA,KaplunJ,StrizhevskyM,KantorY,HolcombK,PoretskyL,Seto-YoungD.Effectsofmitogen-activatedproteinkinase(MAPK)inhibitiononprogesteroneandinsulin-like

growthfactorbindingprotein-1(IGFBP-1)productioninhumanovariancells.88thAnnualMeetingoftheEndocrineSociety,P1-409,Boston,MA,June24-27,2006.

64. PatelP,Seto-YoungD,PoretskyL,LiaoEP.EffectsofvitaminDsupplementationintype2diabetesmellitus.88thAnnualMeetingoftheEndocrineSociety,P2-506,Boston,MA,June24-27,2006.

65. SalibyAH,StachelMW,SantosEM,Seto-YoungD,ZonzseinJ,TranbaughR,PoretskyL.Theeffectofglucose-insulin-potassium infusion and rosiglitazone on the clinical outcome and the circulatinglevelsoffreefattyacidsinpatientsundergoingcoronaryarterybypassgrafting.88thAnnualMeetingoftheEndocrineSociety,P3-659,Boston,MA,June24-27,2006.

66. GurevichY,PoretskyL.Canpamidronatepreventhungrybonesyndromeafterparathyroidectomy?

16thAnnualMeetingandClinicalCongressoftheAmericanAssociationofClinicalEndocrinologists,Abstract#393,Seattle,WA,April11-15,2007.

LEONIDPORETSKY,M.D.

28

67. AvtanskiDB,StrizhevskyM,ParikhG,ArakiT,RosenO,DemetriC,GoldmanM,CadaqS,RosenwaksZ,PoretskyL,Seto-YoungD.Theeffectofthiazolidinedionesonestrogenproductioninhumangranulosecells.89thAnnualMeetingoftheEndocrineSociety,P1-317,Toronto,Canada,June2-5,2007.

68.SongL,Seto-YoungD,LiuL,PoretskyL.Lackofconsistenteffectofinsulin-likegrowthfactorI(IGF-

1)onplasminogenactivatorinhibitortype1(PAI-1)productioninculturedhumanaorticendothelialcells(HAEC).89thAnnualMeetingoftheEndocrineSociety,P3-389,Toronto,Canada,June2-5,2007.

69. MartinezRE,PoretskyL,LamA,KrymskayaM,BurkeG.Diabeteseducationforthedeaf: unexploredterritory.16thAnnualMeetingandClinicalCongressoftheAmericanAssociationof ClinicalEndocrinologists,Abstract#272,Seattle,WA,April11-15,2007.70. BernsteinG,PoretskyL,LamA,KrymskayaM,DeJesusJ,DoyleR,BurkeG,ToweM,WorthingtonB.

Culturally CompententDiabetes Education Program forDeaf Patients. 34th AnnualMeeting of theAmericanAssociationofDiabetesEducators,AbstractCQ01,St.Louis,MO,August1-4,2007.

71. AvtanskiDB,ParikhG,StrizhevskyM,FengY,PareekA,SinghJ,SinghN,PolskayaM,RosenwaksZ,

Seto-Young D, Poretsky L. Thiazolidinediones inhibit estrogen synthesis by interfering withandrogenbindingtoaromatase.90thAnnualMeetingoftheEndocrineSocietyMeeting,AbstractP2-44,SanFrancisco,CA,June15-18,2008.

72. ParikhG,ChlamtacN,RosenwaksZ,PoretskyL,Seto-YoungD.VitaminDreceptor(VDR)is

expressed inhumanovariancells, likelymediating theeffectsofVitaminDon testosterone (T)andprogesterone (P) production. 90th AnnualMeeting of the Endocrine SocietyMeeting, Abstract P2-468,SanFrancisco,CA,June15-18,2008.

73. Poretsky L, DeJesus J, Lam A, Krymskaya M, Mantha K, Burke G. The effects of diabetes self-

managementeducationonHbA1Cindeafpatients.68thScientificSessionsoftheAmericanDiabetesAssociation,Abstract861-P,SanFrancisco,CA,June6-10,2008.

74. AbelevZ,SethA,PatelRR,GoldsteinS,BogunMM,HomelP,BustaA,PoretskyL.Intravenousinsulin

infusion(III),24hrpostoperativecapillarybloodglucose(CBG)andpatientage affect post-surgicallengthofstay(LOS)andcomplicationsinpatientswithdiabetesmellitus(DMundergoingcoronaryarterybypassgraft (CABG). 69thScientificSessionsof theAmericanDiabetesAssociation,Abstract692-P,NewOrleans,LA,June5-9,2009.

75. CadagS,KrymskayaM,DeJesusJ,SrivastavaA,CraigW,RegesterJ,LevineR,MorrowN,PoretskyL.

The effects of a diabetes education program on clinical outcomes in patients with diabetes. 69thScientificSessionsoftheAmericanDiabetesAssociation,Abstract911-P,NewOrleans,LA,June5-9,2009.

76. ArakiT,GoldmanM,VaradinovaM, JoshiP,ChaanineA,SethA,FengY,RosenwaksZ,PoretskyL,

Seto-Young D. The effects of thiazolidinediones (TZD) on aromatase enzyme kinetics in humangranulosecells.91stAnnualMeetingoftheEndocrineSociety,AbstractP3-268,Washington,DC,June10-13,2009.

77. CadagS,KrymskayaM,DeJesusJ,SrivastavaA,CraigW,RegesterJ,LevineR,MorrowN,

Poretsky L. The effects of a diabetes education program on clinical outcomes in patients withdiabetes.36thAnnualMeetingof theAmericanAssociationofDiabetesEducators,Abstract153019,AtlantaGeorgia,August5-8,2009.

LEONIDPORETSKY,M.D.

29

78. SethAK,GajzerDC,SuwandhiP,FengY,KatoS,RomeroC,PatelR,RosenwaksZ,PoretskyL,Seto-

YoungD.Thiazolidinediones(TZDs)InhibitBoneTurnover.92ndAnnualMeetingoftheEndocrineSociety,AbstractP2-184,SanDiego,CA,June19-22,2010.

79. CadagS,PatelR,KahanJ,LiaoEP,PoretskyL.Latentautoimmunediabetesinadults(LADA)with

hightitersofGAD65antibodiesbutlackoflong-terminsulindependence.92ndAnnualMeetingoftheEndocrineSociety,AbstractP3-560,SanDiego,CA,June19-22,2010.

80. ParikhG,Mantha-ThalerK,AyinikalA,PandyaS,JoshiP,HomelP,PoretskyL.Actionfor

DiabetesEducationProgramandTreatment(ADEPT):AnoutreachprogramforSouthAsianpatientswithdiabetes.70thScientificSessionsoftheAmericanDiabetesAssociation,Abstract1032-P,Orlando,FL,June25-29,2010.

81. DeJesusJ,KrymskayaM,ToweM,PoretskyL.Diabetesself-managementeducationforthe

deaf population. 70th Scientific Sessions of the American Diabetes Association, Abstract 1039-P,Orlando,FL,June25-29,2010.

82. AlfonsoB,MedvedovskyB,RapoportD,ArakiT,DubrowA,PoretskyL. Useof hemodialysis in apatient with hyperosmolar hyperglycemic state and rhabdomyolysis – case report and literaturereview.93rdAnnualMeetingoftheEndocrineSociety.AbstractPI-560,Boston,MA,June4-7,2011.

83. Suwandhi P, Pareek A, Sy V, Seth A, Kim SY, Branis N, Seto-Young D, Poretsky L. Effect of

Thiazolidinediones on Osteoblast Biomarkers. 93rd Annual Meeting of the Endocrine Society.AbstractPI-189,Boston,MA,June4-7,2011.

84. DeJesus J, Krymskaya M, Poretsky L. Diabetes Prevention and Management in Hispanic/Latino

Population:TheFriedmanDiabetesInstitute(FDI)Model.AnnualMeetingoftheAmericanDiabetesAssociation,Abstract2153-PO,SanDiego,CA,June24-28,2011.

85. KimSY,SyV,ArakiT,HuangD,KhuranaA,TanD,LiaoE,LiuG,WanS,PoretskyL,Seto-YoungD.

The role of adiponectin in the pathogenesis of gestational diabetes (GDM) in Chinese Americans.ShanghaiInternationalMedicalDevelopmentForumonFamilyMedicine2012,Shanghai,China,May10-11,2012.

86. SyV,KimSY,ArakiT,HuangD,KhuranaA,TanD,LiaoE,LiuG,WanS,PoretskyL,Seto-YoungD.

Decreased total andhighmolecularweight adiponectin are associatedwith gestationaldiabetes inChineseAmericans. 72ndAnnualMeetingof theAmericanDiabetesAssociation,Abstract2539-PO,Philadelphia,PA,June8-12,2012.

87. SyV,KimSY,ArakiT,HuangD,KhuranaA,TanD,LiaoE,LiuG,WanS,PoretskyL,Seto- YoungD.

Totaladiponectin,butnotTNF-α,IL-6orMCP-1,correlateswiththeincreasingglucoseintoleranceinpregnantChinese-Americanwomen. 94thAnnualMeetingof theEndocrineSociety. AbstractSUN-213,Houston,TX,June23-26,2012.

88. Spritzler J, Stein DS, Bilello J, Poretsky L, Pakes G, Mildvan D. Tumor necrosis factor-α soluble

receptor type II level is an independent predictor of HIV disease progression after 8 weeks in aclinical endpoint trial (ACTG 320) in advanced HIV infection. XIX International AIDS Conference,AbstractA-452-0015-03979,Washington,DC,July22-27,2012.

LEONIDPORETSKY,M.D.

30

89. Kim SY, Sy V, Babushkin N, Tan D, Liao EP, Liu G, Wan S, Poretsky L, Seto-Young D. Unlike inCaucasians,FGF-21andRBP4donotdifferinChinese-Americanwomenwithorwithoutgestationaldiabetes.95thAnnualMeetingoftheEndocrineSociety,AbstractSAT-809,SanFrancisco,CA,June15-18,2013.

90. HirthY,BabushkinN,SyV,SethAK,PareekAS,LinYK,PoretskyL,Seto-YoungD.

ThiazolidinedioneeffectsonthemineralcontentandthecomponentsoftheWntsignalingpathwayin the human osteoblasts. 95th Annual Meeting of the Endocrine Society, Abstract SUN-214, SanFrancisco,CA,June15-18,2013.

91. StrikerGE,Yubero-SerranoEM,SwamyS,ElliotSJ,CaiW,ChenX,McKeeE,,KalajA,KruckelmanF,Tirri L, Mantha K, Rayfield EJ, Uribarri J, Harbord N, Tamler R, Parikh G, Busta A, Poretsky L,Woodward M, Vlassara H. Reversal of suppressed estrogen receptor α and anti-oxidant levels:Possible benefits for cardiovascular disease (CVD) in diabetic kidney disease (DKD). 95th AnnualMeetingoftheEndocrineSociety,Abstract80-LB,SanFrancisco,CA,June15-18,2013.

92. BustaA,PoretskyL,Yubero-SerranoE,WoodwardM,VlassaraH,StrikerGE.TheeffectofSevelamer

on oxidant stress and albuminuria in patients with type 2 diabetes and kidney disease: Arandomized, controlled study. 7th Annual Friedman Fellows Symposium at the 74th ScientificSessionsoftheAmericanDiabetesAssociation,SanFrancisco,CA,June13-17,2014.

93. OngEC,PatelR,PoretskyL.Anatypicalpresentationofpituitarysarcoidosis:Acasereport.16thInternational Congress of Endocrinology andTheEndocrine Society 96thAnnualMeeting, AbstractSAT-0707,Chicago,IL,June21-24,2014.

94. Striker GE, Yuberro-Serrano E, Poretsky L, Vlassara H. Control of oral advanced glycation

endproducts(AGEs)bysevelamercarbonateimprovesglucosemetabolismandalbuminuriainStage2-4diabetickidneydisease(DKD).16thInternationalCongressofEndocrinologyandTheEndocrineSociety96thAnnualMeeting,AbstractSAT-0988,Chicago,IL,June21-24,2014.

95. IslamJR,Seto-YoungDLT,LesserM,RosenwaksZ,PoretskyL. Doesirisinhaveaneffectonfemalereproductivefunction?Initialin-vitrostudies.16thInternationalCongressofEndocrinologyandTheEndocrineSociety96thAnnualMeeting,AbstractMON-0053,Chicago,IL,June21-24,2014.

96. Kambo V, Wakim W, Poretsky L. Readmission rates for patients with secondary diagnosis of

diabetes are increased regardles of primary diagnosis. Endocrine Society 97th Annual Meeting,AbstractTHR-184,SanDiego,CA,March5-8,2015.

97. Kambo, V., Lutsky, L., Poretsky L. Extremely short (1day) length of stay (LOS) in patients withdiabetes(DM)isassociatedwithhighreadmissionrates(RR).75thAnnualMeetingoftheAmericanDiabetesAssociation,Abstract1370-P,Boston,MA,June5-9,2015.

98. AvtanskiDB,HirthY,BabushkinN,SyV,SharmaD,PoretskyL,Seto-YoungDL. InVitroeffectsofpioglitazone on the expression of Wnt signaling pathway components and markers of bonemineralization.EndocrineSociety98thAnnualMeeting,Abstract,Boston,MA,April1-4,2016.

LEONIDPORETSKY,M.D.

31

99. AvtanskiD,KuppusamyP,SonmezH,ShnayderV,WolfeA,PavlovVA,TraceyKJ,PoretskyL.Plasmalevelsofresistincorrelatewithadenylylcyclase-associatedprotein1(CAP1)indiet-inducedobesitymousemodel. EndocrineSociety99thAnnualMeeting,Abstract#SAT-573,Orlando,FL,April1-4,2017.

100. Sonmez H, Kambo V, Lutsky L,Poretsky L. The readmission rates in patients with and without

diabetes mellitus at an urban teaching hospital. 77th Annual Meeting of the American DiabetesAssociation,Abstract1352-P,SanDiego,CA,June9-13,2017.

101. AvtanskiD,GarciaA,CaraballoB,ThangeswaranP,Bianco J,LaviA,MarinS,RoncaC,PoretskyL.

Resistin increases breast cancer cell motility and induces cellular mesenchymal reprograming.EndocrineSociety100thAnnualMeeting,Abstract#SAT-329,Chicago,IL,March17-20,2018.

102. AvtanskiD,GarciaA,ThangeswaranP, CaraballoB, LaviA,Bianco J,Marin S,RoncaC,PoretskyL.Resistininhibitsinsulinsignalinginadenylylcyclase-associatedprotein1(CAP1)-dependentmanner.EndocrineSociety100thAnnualMeeting,Abstract#SUN-141,Chicago,IL,March17-20,2018.

103. Avtanski D, Garcia A, Thangeswaran P, Caraballo-Bordon B,Poretsky L. Role of adenylyl cyclase-associatedprotein1(CAP1)inmediatingresistinactionsinmouselivercells.78thAnnualMeetingoftheAmericanDiabetesAssociation,Abstract1754-P,Orlando,FL,June22-26,2018.

104.ChenK,WeberD,SatlofL,LaviA,BahlK,KaiserM,PoretskyL,AvtanskiD.Resistininducesepithelial

to mesenchymal transition (EMT) in breast cancer cells through activation of AXL tyrosine kinasereceptor.EndocrineSociety101thAnnualMeeting,Abstract#5553,NewOrleans,LA,March22-26,2019.

105. Avtanski D, Lavi A, Bahl K, Kaiser M, Weber D, Satlof L, Chen K, Poretsky L. Proinflammatory

cytokines modulate resistin expression in breast cancer cells. Endocrine Society 101th AnnualMeeting,Abstract#5562,NewOrleans,LA,March22-26,2019.

106. Sajan A, Paliou M, Colon D, Ziskovich K, Poretsky L. Improving transgender care through

comprehensive wellness program in the Endocrine Division: Early experience. Endocrine Society101thAnnualMeeting,Abstract#5781,NewOrleans,LA,March22-26,2019.

107. BasmanC,AvtanskiD,ZiskovichK,JonasR,FishmanS,SonmezH,RashidU,KodraA,StoffelsG,Lesser

M,SinghV,PoretskyL.Serumlevelsoftheadvancedglycationendproduct(AGE)pentosidinedonotcorrelatewiththeextentofcoronaryarterydiseaseassessedbySYNTAXscore.79thAnnualMeetingoftheAmericanDiabetesAssociation,Abstract2215-PUB,SanFrancisco,CA,June7-11,2019.

U.S.PATENTS:1. PoretskyL.U.S.Patent#4,861,073Newspaperholder,1989.

2. PoretskyL, Seto-YoungD. Use of thiazolidinediones for partial inhibition of androgen binding to

aromatase.U.S.PatientApplicationNo.12/463,522.Patentpending,2009.

LEONIDPORETSKY,M.D.

32

OTHER:1. SilverR,PoretskyL, Flier JS. TreatmentofNecrobiosis LipoidicaDiabeticorum. JAmerMedAssoc

254:3,422-423,1985(Letter).2. Acknowledgment:Experimentalworkpublished inGrigorescuF, Flier JS,KahnCR. Defect in insulin

receptorphosphorylationinerythrocytesandfibroblastsassociatedwithsevereinsulinresistance. J.BiolChem259:15003-15006,1984.

3. Novic D,Poretsky L, KalinM. Thyroid-function tests in patients treatedwithmethadone. Clinical

Chemistry35:1807-1808,1989(Letter).4. PoretskyL.Specificity-spilloverphenomenoninthehumanovary.NEnglJMed,321:7,p.474,1989

(Letter).5. Acknowledgment:Helpfulcommentspublished inSingerF,TalaveraW,ZumoffB. Elevated levelsof

anotensin-coveringenzymeinpneumocystiscariniipneumonia.Chest95;803-806,1989.6. PoretskyL.Medicaidproposal.TheNewYorkTimes,July20,1990;pA26(Letter).7. PoretskyL.OvarianInsulin-likeGrowthFactors.AnnInternMed.117-:535,1992(Letter).

8. PoretskyL.ChoicesforPatients(letter),TheNewYorkTimes,November30,1993.9. PoretskyL.DiagnosticScale(letter).TheNewYorkTimes,June18,1994.10. Rodriguez G.Poretsky L. Toradol Instead of Tapazole (letter). American Journal ofHealth System

Pharmacy,Vol52:1098,1995.11. StolarczykR,LauferI,PoretskyL.ReplytoEriksson.DiabCare20:1045,1997(letter).12. PoretskyL.Purchase(shortstory).NovoyeRusskoeSlovo(NewRussianWord,RussianDaily Newspaper):p62,November,7,1997.13. PoretskyL.“ChanukahinNewYork”MetropolitanDiary,TheNewYorkTimes,January26,1998.14. PoretskyL.Interviewedfor“Populardrugfordiabetesisscrutinized”byDavidMorrow,The NewYorkTimes,March26,1999.15. PoretskyL.Chichikov’sList(letter)TheNewYorkTimes,April9,1999.16. PoretskyL.“Greatblueheron”(apoem).OutdoorMagazine,Fall2000,p.13.17. PoretskyL.“Thebearstanza”(apoem).TheRiverReporter,Jan4th-10thissue,2001.18. PoretskyL.“Runningdeer”(apoem).TheRiverReporter,May24,2001.19. PoretskyL.Interviewedfor“Bristol-Meyersfightstolockinpatients”byGardinerHarris,WallStreet

Journal,May21,2001.20. PoretskyL.“Businessisbusiness”,MetropolitanDiary,TheNewYorkTimes,October8,2001.

LEONIDPORETSKY,M.D.

33

21. PoretskyL.“Hareinthepark”(apoem).OutdoorsMagazine,p.75,October,2001.

22. Poretsky L. Interviewed for “Abbot pushes its Synthroid, but should it?” by Gardiner Harris,Wall

StreetJournal,July17,2002.

23. PoretskyL.“Anoutdooradventure”(apoem).RiverReporter,August15-21,2002.

24. PoretskyL.“Tofallinlove”(apoem).RiverReporter,February13-19,2003.25. PoretskyL.Interviewedfor“Inthetreatmentofdiabetessuccessoftendoesnotpay”.TheNewYork

Times,January11,2006.

26. PoretskyL.Interviewedfor“$6milliongiftresurrectsabootcampfordiabetics”.TheNew YorkTimes,April2,2006.27. PoretskyL.Interviewedfor“Whatyourdoctorisn’tsaying”.Men’sHealth,p.177,November 2006.28. PoretskyL.“Bonus”,MetropolitanDiary,TheNewYorkTimes,December25,2006.29. PoretskyL.“Mother’shand”(apoem).JewishCurrents,May-June2007.30. PoretskyL.Interviewedfor“Victoriesoverdiabetes”.DailyNews,October28,2007.31. PoretskyL.Interviewedfor“BethIsraelMedicalCenterInauguratesTheGeraldJ.Friedman DiabetesInstitute.”MedicalUpdate8:4,December2007.32. PoretskyL.“IceCreamandTolstoy,”MetropolitanDiary,TheNewYorkTimes,December3, 2007.33. PoretskyL.Interviewedfor“Bedeviledbythesugarsickness,”TheNewYorkTimes,March2,2008.34. PoretskyL.Interviewedfor“Regulatorsscuttledrugfordiabetes,“TheWallStreetJournal, September24,2010.37. PoretskyL.“Choiceswemake,”MetropolitanDiary,TheNewYorkTimes,June27,2011.

37. PoretskyL.Re:“Betteruseofmedicalrecordsisgoodasfarasitgoes,”LettertotheEditor,TheWall

StreetJournal,September26,2011.38. Poretsky L. Re: “At what age would it be appropriate to perform genetic testing for diabetes?”

Point/Counter,EndocrineToday,p.11,September2011.39. PoretskyL.Galleryexhibit:“Bemine…always”,anexhibitionoflovepoemsandphotos.Poem:“Your

Lips” by Leonid Poretsky and an art object by Leonid Poretsky and Lee Clayton. Alliance Gallery,Narrowsburg,NewYork,January28-February18,2012.

LEONIDPORETSKY,M.D.

34

40. PoretskyL. Re:“Meetthemarriagekiller,”LettertotheEditor,TheWallStreet Journal,February8,2012.

41. PoretskyL.TheAGE-LessWay(onlinebookreview),Amazon.com,July23,2012.42. Poretsky L. The Jewish plot: A story. On line: http://jewishcurrents.org/the-jewish-plot-a-story-

16445,April15,2013.Inprint:“JewishCurrents”,pp40-42,Summer2013.43. Poretsky L. Re: “Physician, hear thyself—Why communicationmatters,” Letters to the Editor, The

WallStreetJournal,April20-21,2013.44. Poretsky L. Re: “Readmissions often aren’t culpable acts.” Letters to the Editor, TheWall Street

Journal,May20,2013.45. PoretskyL. Re: “TraditionalMedicareshouldbeallowedtocompete.” EducationUpdate,Vol.XXII,

No.3,pp14,January/February2017.46. PoretskyL.ConceptualArtEvent:“Thankyouforcoming.”DaciaGallery,NewYork,May20,2017.47. PoretskyL.LHHAuxiliaryPhotoContest:“GoodMorningNewYork.”Honorablemention,November

12,2019,NewYork.

VOLUNTEERING:January17-24,2015VolunteerPhysicianfortheUnitedStatesBobsledandSkeletonFederationEurope

CupSkeletonTeam.-SaintMoritz,Switzerland-Innsbruck,Austria

LEONIDPORETSKY,M.D.

35

TRAINEES

Name

LevelofTrainee

RoleinTrainingandInclusive

DatesofTraining

TrainingVenue

Trainees’CurrentStatus/Employment

MarshaTolentino,MD

EndocrineFellow

07/01/99–06/30/01

MentorforClinicalResearch

PrivatePractice,Cebu,Philippines

AnilShrestha,MD

EndocrineFellow

07/01/99–06/30/01

MentorforClinicalResearch

Endocrinologist,BaptistMedicalCenter,FL

SusanZweig,MD

EndocrineFellow

07/01/00–06/30/02

MentorforClinicalResearch

Endocrinologist,NewYorkUniversity

JacekZajac,MD

EndocrineFellow

07/01/00–06/30/02

MentorforClinicalResearch

EndocrinologistElmhurstHospital,IL

AndreaFerenczi,MD

EndocrineFellow

07/01/01-06/30/03

MentorforClinicalResearch

Endocrinologist,BannerBoswellMedicalCenter,AZ

MarziehSalehi,MD

EndocrineFellow

07/01/01-06/30/03

MentorforClinicalResearch

Endocrinologist,CedarsSinaiMedicalCenter,TX

AidaSaliby,MD

ECRIPFellow/Endocrinologist

07/01/0206/30/15

MentorforClinicalResearch

Chief,EndocrineNYPHDowntown,NY

RafaelBravo-Vera,MD

EndocrineFellow

07/01/02-06/30/04

MentorforClinicalResearch

EndocrinologistNovartis,MexicoCity

ArsalanSheikh,DO

EndocrineFellow

07/01/02-06/30/04

MentorforClinicalResearch

Endocrinologist,UniversityofMarylandMedicalCenter

MariaPaliou,MD

EndocrineFellow

07/01/03-06/30/05

MentorforClinicalResearch

Chief,Endocrine,HarlemHospital,NY

JonathanSchlosser,DO

EndocrineFellow

07/01/03-06/30/05

MentorforClinicalResearch

Endocrinologist,NyackHospital

JuliaKaplun,MD

EndocrineFellow

07/01/04-06/30/06

MentorforClinicalResearch

Endocrinologist,NyackHospital

LisenLiu,MD

EndocrineFellow

07/01/04-06/30/06

MentorforClinicalResearch

PrivatePractice,NewYorkCity

PariniPatel,MD

ECRIPFellow/EndocrineFellow

07/01/04-06/30/08

MentorforClinicalResearch

Endocrinologist,HackensackMeridian,NJ

DimitarAvtanski,Ph.D.

Fellow-ThankstoScandinavia

2004-2008

MentorforClinicalResearch

Director,FriedmanEndocrineLaboratoryLHH

MarinaStrizhevsky,DO

ECRIPFellow/EndocrineFellow

07/01/05-06/30/09

MentorforClinicalResearch

EndocrinologistJerseyCityMedicalCenter

DimaYeshou,MD

IMResident

2005

MentorforClinicalResearch

Endocrinologist,HackensackUniversity,NJ

RamonE.Martinez,MD

EndocrineFellow

07/01/05-06/30/07

MentorforClinicalResearch

Endocrinologist,MountSinaiMedicalCenter,FL

LiqunSong,MD

EndocrineFellow

07/01/05-06/30/07

MentorforClinicalResearch

Endocrinologist,GriffinHospital,CT

YuriyGurevich,DO

EndocrineFellow

07/01/06-06/30/08

MentorforClinicalResearch

Endocrinologist,NyackHospital

MichaelGoldman,MD

ECRIPFellow

2007

MentorforClinicalResearch

Nephrologist–JamaicaHospital,Queens,NY

LEONIDPORETSKY,M.D.

36

Name

LevelofTrainee

RoleinTrainingandInclusive

DatesofTraining

TrainingVenue

Trainees’CurrentStatus/Employment

ZinovyAbelev,MD

EndocrineFellow

07/01/07–06/30/09

MentorforClinicalResearch

Endocrinologist,NorthwellHealth

StefanCadag,DO

EndocrineFellow

07/01/08-06/30/10

MentorforClinicalResearch

Endocrinologist,MountSinaiBethIsrael

SagitZolotov,MD

EndocrineFellowResearchTrack

07/01/0506/30/10

MentorforClinicalResearch

PrivatePractice,Israel

GrishmaParikh,MD

ECRIPFellowFriedmanFellowEndocrineFellow

07/01/07–06/30/10

MentorforClinicalResearch

Endocrinologist,AssistantProfessor,IcahnSchoolofMedicine

BiancaAlfonso,MD

ECRIPFellowEndocrineFellow

01/01/07-06/30/11

MentorforClinicalResearch

Endocrinologist,SouthMiamiHospital

TakakoAraki,MD

FriedmanFellowEndocrineFellow

07/01/08-06/30/11

MentorforClinicalResearch

Endocrinologist,UniversityofMinnesota

YunFeng,MD

EndocrineFellow

07/01/10-06/30/12

MentorforClinicalResearch

Endocrinologist,MountSinaiBethIsrael

AmitSeth,MD

ECRIPFellow/EndocrineFellow

07/01/09-06/30/12

MentorforClinicalResearch

Endocrinologist,NewarkBethIsraelMedicalCenter

GordonBurke,MD

MedicalStudent

2009

MentorforClinicalResearch

Internist,BostonUniversityFamilyGroup

PrajeshM.Joshi,MD

IMResident

2009

MentorforClinicalResearch

Endocrinologist,MercyHospital,Arkansas

MiroslavaVaradinova,PhD

ResearchFellow

2009

MentorforClinicalResearch

Sofia,Bulgaria

DavidGajzer,MD

FriedmanFellowResearchFellow

2010

MentorforClinicalResearch

Fellow–Anesthesiology,Miami,FL

SumeiKato,MD

IMResident

2010

MentorforClinicalResearch

OncologistUCSanDiego

PaulineSuwandhi,MD

FriedmanFellow

2010

MentorforClinicalResearch

Geriatrics,MontefioreHospital

DinaRapoport,MD

IMResident

2011

MentorforClinicalResearch

Endocrinologist,NYUHospital

So-YoungKim,MD

IMResident

2011

MentorforClinicalResearch

Endocrinologist,WeillCornellMedicine

NataliaBranis,MD

IMResident

2011

MentorforClinicalResearch

EndocrinologistMountSinaiBethIsrael

NicoleBabushkin

ResearchAssistant

2012

MentorforClinicalResearch

Internist,OceanMedicalCenter,NJ

VanessaSy-Po,MD

Volunteer

2012

MentorforClinicalResearch

FMLA–BirthofChild

JulieIslam,MBBS

ResearchFellow/FriedmanFellow

07/01/12–06/30/14

MentorforClinicalResearch

EndocrineFellow,Scripps,LaJolla,CA

LEONIDPORETSKY,M.D.

37

Name

LevelofTrainee

RoleinTrainingandInclusive

DatesofTraining

TrainingVenue

Trainees’CurrentStatus/Employment

CarlaRomero,MD

EndocrineFellow

07/01/11-06/30/13

MentorforClinicalResearch

Endocrinologist,NorthShoreLIJ-Northwell

RonakPatel,MD

EndocrineFellow

07/01/12-06/30/14

MentorforClinicalResearch

Endocrinologist,MorristownMedicalCenter,NJ

ZiJianChen,MD

EndocrineFellow

07/01/12-06/30/14

MentorforClinicalResearch

Endocrinologist,MountSinaiMedicalCenter

ErwynOng,MD

EndocrineFellow

07/01/13-09/01/14

MentorforClinicalResearch

Endocrinologist,PresbyterianMedicalGroup,NewMexico

HalisSonmez,MD

EndocrineFellow/ECRIPFellow

07/01/13-09/01/14;12/01/15–04/04/17

MentorforClinicalResearch

Endocrinologist,NYUQueensHospital,NY

MahmoudHassan,MD

ResearchFellow

01/01/14–09/01/14

MentorforClinicalResearch

Master’sProgram,JohnHopkinsUniversity,Baltimore,Maryland

SarahFishman,MD

EndocrineFellow

07/01/16–06/30/18

MentorforClinicalResearch

AttendingEndocrinologistLenoxHillHospital

TrishaNewaz,DO

EndocrineFellow

09/27/17–Present

MentorforClinicalResearch

EndocrineFellowLenoxHillHospital

ArpitaBhalodkar,MD

ECRIPFellow/EndocrineFellow

08/01/17-06/30/18;07/01/18-Present

MentorforClinicalResearch

EndocrineFellowLenoxHillHospital

MikailKoroma,MD

ECRIPFellow

02/01/18–07/31/18

MentorforClinicalResearch

OrthopedicResidencyLenoxHillHospital

KarinChen,MD

ECRIPFellow

09/04/18–Present

MentorforClinicalResearch

JuniorAttendingPhysicianDivisionofEndocrinology–LenoxHillHospital

AlenSajan,MD

IMResident

11/2018toPresent

MentorforClinicalResearch

InternalMedicineSpecialistLenoxHillHospital

LEONIDPORETSKY,M.D.

38